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 Eukaryotic transcription and mRNA processing depend upon the 
coordinated interactions of many proteins, including Spn1 and Spt6, which are 
conserved across eukaryotes, are essential for viability, and associate with each 
other in some of their biologically important contexts. Spt6 functions at several 
important regulatory steps in transcription, including nucleosome reassembly, 
transcription elongation, and mRNA processing and export. As a histone 
chaperone, Spt6 is important for reassembly of nucleosomes in the wake of 
elongating RNA polymerase II, a process that is required to regulate transcription 
initiation and prevent inappropriate transcription from repressed promoters as 
well as cryptic intragenic transcription start sites. In conjunction with Spt6, Spn1 
coordinates the recruitment of mRNA processing and export factors, such as 
Yra1 and the exosome, thereby enabling biogenesis of mature and export 
competent mRNA molecules. The functional relevance of Spn1 and Spt6 in 
chromatin organization and mRNA maturation is well established, although 
mechanistic details of how these processes are performed are poorly 
understood.  In order to enhance our understanding of the molecular details of 
Spn1 and Spt6 functions, this thesis has focused on structural, biochemical and 
functional studies of Spn1 and Spt6 from Saccharomyces cerevisiae.    
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 The work presented in this dissertation establishes the structures of the 
entire ordered region of the Spt6 protein, the ordered core of the Spn1 protein, 
and the Spn1 core in complex with the binding determinant of Spt6.  Additionally, 
we demonstrate the capacity of Spt6 to interact with factors that very likely 
influence Spt6 function, including histones and nucleosomes.  The structures and 
the functional data described in this dissertation have enhanced our 
understanding of how Spt6 binds and chaperones histones, and describes a 
novel role for Spn1 in regulating the histone chaperone activity of Spt6.   The 
Spt6 and Spn1 structures and the biochemical assays developed in this work will 
aid in future functional and mechanistic studies that will aim to develop a 
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Transcription and Biogenesis of mRNA 
 
The process of transcription is the synthesis of RNA molecules from a 
DNA template.  RNA molecules play numerous roles in many cellular processes, 
including peptidyl-transferase activity during protein synthesis (Ramakrishnan, 
2002), splicing of messenger RNA (mRNA) molecules (Semlow and Staley, 
2012), and the inhibition of transcription and translation (Mello and Conte, 2004; 
Verdel et al., 2004).  Fascinatingly, the emergence of enzymatically active RNA 
molecules, such as self-replicating ribozymes, may have been a critical early step 
in the development of life on earth (Johnston et al., 2001).  RNA polymerase 
(RNAP) is the multi-subunit enzyme that catalyzes the polymerization of 
ribonucleotides into RNA chains that are complimentary to the DNA template 
(Hurwitz, 2005).  RNAP enzymes are essential to life and are found in every 
organism, including some viruses (Ahlquist, 2002; Korkhin et al., 2009).  The 
RNAP from bacteria is structurally and mechanistically related to each of the 
three types of RNAPs in eukaryotes, RNA polymerase I, II and III (Ebright, 2000).  
The most highly studied eukaryotic RNAP is RNA polymerase II (RNAPII), which 
is responsible for transcribing protein coding genes, the precursors to mRNA, 
and most microRNAs (Lee et al., 2004).  The transcriptional process in modern 
organisms, from bacteria to humans, employs strikingly similar topological 
features (Kornberg, 2007; Zakrzewska and Lavery, 2012), and consists of three 
major steps, initiation, elongation, and termination (Figure 1-1A and B).  The 
following discussion will focus primarily on eukaryotic transcription. 
 
 
From initiation to elongation 
 
Initiation begins with assembly of the pre-initiation complex and 
recognition of core promoter elements within genomic DNA.  In bacteria, RNAP is 
aided in promoter recognition by sigma factors (Feklistov and Darst, 2011), 
whereas eukaryotic RNAPII utilizes a set of general transcription factors 
unrelated to their bacterial counterparts (Figure 1-1A) (Liu et al., 2011).  After 
promoter recognition, the DNA is partially unwound to form an open complex that 
allows the DNA to enter the active site of the enzyme (Goodrich and Tjian, 1994; 
Kornberg, 2007).  Synthesis of the first 8-9 ribonucleotides produces a DNA-RNA 
heteroduplex, which stabilizes the open complex, permits promoter escape, and 
the transition to the elongation step (Kornberg, 2007).  Although the precise 
determinants of the transition to an elongation competent complex are not 
known, most evidence suggests that the length of the nascent transcript is crucial 
for making contacts to RNAPII that allow collapse of the transcription bubble and 
escape from the promoter region (Luna et al., 2008).  
2
!Figure 1-1.  Overview of Transcription and mRNA Maturation 
Adapted from (Luna et al., 2008) 
A) Simplified diagram of the first steps of transcription from initiation to 
productive elongation.  Initiation in eukaryotes is aided by general 
transcription factors such as TFIIH.  Promoter-proximal pausing induced 
by the Spt4/Spt5 complex (DSIF) and NELF coincides with 5’-end capping 
of the nascent mRNA transcript.  Release from pausing to productive 
elongation requires the kinase activity of PTEF-b 
B) Schematic of the co-transcriptional processing of nascent transcripts 
required to produce mature, export competent mRNA molecules.  
Capping, splicing and 3’-end processing are regulated co-transcriptionally 
and export from the nucleus requires adaptor proteins that bind the mRNA 
















 Promoter escape in eukaryotes coincides with the start of the 
phosphorylation cycle of the C-terminal domain of the largest subunit of RNAPII 
(RNAPII-CTD).  The RNAPII-CTD consists of heptapeptide repeats of the 
sequence YSPTSPS, where each of the serines, as well as the tyrosine, can be 
phosphorylated (Mayer et al., 2012).  This domain serves as a scaffold for 
recruiting a number of factors whose binding depends on the phosphorylation 
pattern of the RNAPII-CTD, which changes throughout the transcription cycle and 
coordinates different events in the maturation of the mRNA molecule 
(Buratowski, 2003; Luna et al., 2008).  Prior to becoming a wholly productive 
elongation complex, continued adjustments are made to the complex that leads 
to transcriptional pausing near the promoter region.  Factors such as the 
Spt4/Spt5 complex and negative elongation factor (NELF) bind the transcription 
complex and inhibit transcription (Saunders et al., 2006).  Release from this 
inhibition into productive elongation requires phosphorylation events mediated by 
the positive transcription elongation factor complex-b (PTEF-b), which 
phosphorylates the Spt4/Spt5 complex, NELF, and the RNAPII-CTD (Figure 1-
1A) (Bres et al., 2008).  The Spt4/Spt5 complex remains associated to the 
elongation complex in accordance with its positive role in transcription elongation 






Transcription termination occurs after passage of the polyadenylation 
(polyA) signal by the elongation complex.  Nascent mRNA molecules are typically 
cleaved 20-30 nucleotides downstream of the polyA signal by the concerted effort 
of several 3ʼ-end processing factors (Luna et al., 2008).  After cleavage, polyA 
polymerase adds the polyA tail, and the tail is bound by polyA binding proteins 
that protect the transcript from degradation (Figure 1-1B) (Luna et al., 2008).  
Two mechanistic and non-mutually exclusive models have been proposed to 
explain termination (Buratowski, 2005; Rosonina et al., 2006).  The first is an 
ʻallostericʼ model in which conformational changes within the elongation complex 
following the passage of the polyA signal cause a decrease in processivity and 
subsequent disassembly.  In support of this model, a single cleavage factor has 
been shown to efficiently disassemble paused elongation complexes (Zhang et 
al., 2005; Zhang and Gilmour, 2006).  The second model, the ʻtorpedoʼ 
termination model, proposes that the exonucleolytic degradation of the uncapped 
nascent transcript that remains after cleavage of the pre-mRNA at the polyA 
signal somehow signals the elongation complex to terminate.  Support for this 
model comes from observations that the 5ʼ-3ʼ exonuclease XRN2 in humans 
(Rat1 in yeast) is required for efficient termination (Kim et al., 2004; Luo et al., 




mRNA processing and quality control 
 
It is important to note that the processing required for production of 
mature, stable, and export competent mRNA molecules occurs co-
transcriptionally (Figure 1-1B) and begins once the nascent transcript emerges 
from RNAPII (Luna et al., 2008).  Capping of the nascent transcript, the methyl 
guanylation of the 5ʼ-end, happens coincidentally with promoter-proximal pausing 
(Moteki and Price, 2002; Rasmussen and Lis, 1993); likely serving as a 
checkpoint to ensure that only properly capped transcripts are extended.  The 
cap-binding protein complex then binds the monomethyl cap and is required for 
further maturation events including splicing and export from the nucleus 
(Izaurralde et al., 1994).  Some of the required 3ʼ-end processing factors 
associate with promoter regions, implying that initiation and termination are 
connected and may impact each otherʼs efficiency (Krishnamurthy et al., 2004; 
Mayer et al., 2012).  The splicing, or removal of introns from the nascent 
transcript, can occur during or after transcription, and ensures that the correct 
protein code is contained within the transcript (Semlow and Staley, 2012).   RNA-
binding proteins, such as Yra1 (REF1/Aly in humans), are recruited to the 
transcription elongation complex and are required for mRNA export to the 
cytoplasm (Johnson et al., 2009; Strasser and Hurt, 2000; Yoh et al., 2007).  
Improperly processed transcripts are retained in the nucleus and degraded by the 
nuclear exosome complex (Saguez et al., 2005), while factors at nuclear pore 
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complexes also contribute to the transcriptional quality control mechanism (Galy 
et al., 2004).   
 
 
Transcription in the Context of Chromatin 
 
The cells of all organisms contain DNA molecules that constitute the 
genome and provide a blueprint or code for all aspects of cell survival.  The 
fundamental difference between bacteria and eukaryotes is that bacterial cells 
are not partitioned into intracellular compartments or organelles, their biology is 
less complicated, and as such, their genomes are smaller and not sequestered in 
a membrane bound nucleus.  The DNA molecules in human cells are extremely 
long, on the order of two meters if all molecules were stitched together, and 
eukaryotic organisms have therefore evolved an effective packaging system 
termed chromatin that enables the compaction and storage of the genome inside 
the nucleus of each cell (Li and Reinberg, 2011).  It is not simply enough to 
package efficiently, however, because much of the DNA needs to be accessed 
on a regular basis, and chromatin therefore needs to be dynamic.  For example, 
every time a cell divides the entire genome must be replicated; a process that 
requires access to the DNA.  Similarly, the synthesis of RNA and protein 
molecules that drive cellular processes requires accessing, processing, and 
repackaging relevant segments of the genome.  Thus, packaging, accessing, and 
repackaging of genomic DNA is intimately linked to biological function and is 
highly regulated.  This intimate link can have profound consequences if there is 
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even a slight error in any of the regulatory steps of genomic access. Errors in 
these processes can vary in severity from simple replication or transcription 
mistakes, which can be corrected by inherent cellular proofreading and repair 
pathways, to catastrophic defects leading to cell death or uncontrolled cellular 
proliferation as in tumor formation and cancers (Cairns, 2001).  The complexity of 
genomic regulation and our continuing advancement in understanding these 








The overall structure and regulation of chromatin is nearly identical from 
single-celled yeasts to multicellular organisms and humans (Li and Reinberg, 
2011).  Chromatin structure ranges from highly condensed mitotic chromosomes 
to single nucleoprotein complexes called nucleosomes (Figure 1-2).  The 
nucleosome is the fundamental repeating unit of chromatin and consists of 
approximately 150 bp of DNA wrapped around an octameric protein core made of 
two copies of each of four core histone proteins, H2A, H2B, H3, and H4 (Luger et 
al., 1997).  Beyond the packaging into individual nucleosomes, higher order 
chromatin compaction is classified by a hierarchical scheme (Li and Reinberg, 
2011).  Repeating units of single nucleosomes connected by regions of free DNA 
is the most basic level of chromatin organization and resembles ʻbeads on a 
9
!Figure 1-2.  Overview of the Hierarchy of Chromatin Structure 
Adapted from (Lodish et al., 2000; and Li and Reinberg, 2011) 
A) Diagram of the three tiered hierarchical classification scheme for 
chromatin compaction states. 
B) Competing models for the arrangement of nucleosomes within the 30 
nm fiber highlight the varied degree of compaction, and the likelihood of 





stringʼ.  Further compaction is loosely defined by internucleosomal contacts likely 
mediated through the N-terminal tails of the histone proteins resulting in a fiber 
approximately 30 nm in diameter.  Precise arrangement of nucleosomes within 
the fiber remains unknown despite continuing efforts (Li and Reinberg, 2011), 
and is likely to be dynamic with a multitude of conformations. The nature of the 
interactions required to further compact the fibers are also poorly understood, 
and seem to vary with tissue type and cell cycle phase.  
 Chromatin can be separated into two distinct types in nondividing cells 
called heterochromatin and euchromatin (Kwon and Workman, 2011).  
Heterochromatin is condensed, tightly packed, and is generally associated with 
silenced portions of the genome such as centromeres, telomeres, and genes 
whose protein products are not required for specific tissue or cell types.  
Euchromatin is lightly packed and is where the majority of gene transcription 
takes place.  The efficacy of chromatin organization extends beyond a means for 
genome compaction, and is intimately linked to nearly all nuclear processes 
including transcription, DNA replication and repair, and kinetochore and 
centromere formation.  Although chromatin regulation of nuclear processes is 
ubiquitous, the role of nucleosomes in transcription has led to a greater 
understanding of the explicit contributions of chromatin to cellular function. 
When the discovery was made that eukaryotic DNA was packaged into 
nucleosomes it was clear that higher-ordered chromatin assemblies would be a 
significant impediment to transcription (Kornberg, 1974; Kornberg and Lorch, 
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1992).  Because RNAPII requires a relatively free DNA template to synthesize 
mRNA molecules, the presence of nucleosomes throughout the length of a given 
gene would severely encumber mRNA and hence protein synthesis (Saunders et 
al., 2006).  An enormous amount of research in the past 15 years has shown that 
histones are not simply inert obstacles, but specifically contribute to the 
regulation of gene transcription.  Histones can regulate the specificity of gene 
transcription through covalent modifications that function to recruit activating or 
repressive protein factors or prevent repressive higher-order chromatin 
assemblies (Li and Reinberg, 2011). Histones also serve as steric blocks to the 
underlying genetic information, with displacement of intimate histone-DNA 
contacts being achieved through ATP-dependent and independent processes 
(Tyler, 2002). Consequently, the assembly and architecture of the nucleosome is 
central to the regulation of gene expression, as virtually all regulatory processes 





Timothy Richmond and colleagues published the first high-resolution 
structure of the nucleosome core particle in 1997 (Luger et al., 1997).  Prior to 
this, the disc-like shape and the general composition of the nucleosome were 
already well established (Kornberg, 1977; Thomas and Kornberg, 1975).  The 
four core histone proteins each adopt a fold with a helix-turn-helix-turn-helix 
motif, termed the histone fold, as well as partially disordered N-terminal ʻtailsʼ 
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(Figure 1-3).  These ʻtailsʼ are highly enriched in lysine, arginine, and serine 
residues that are capable of accepting covalent modifications that aid in the 
regulation of gene expression (Henikoff, 2008; Jenuwein and Allis, 2001; 
Kouzarides, 2007). The histone fold is optimal for dimerization and protein-
protein interactions required for formation of the core histone octamer, around 
which approximately 150 bp of DNA is wrapped (Sullivan and Landsman, 2003).  
Each histone protein is relatively small, ranging from 10-13 kDa, and highly basic 
on the accessible surface where direct contacts are made with the negatively 
charged phosphodiester backbone of the DNA.  Within the octameric core the 
histones are packaged as a heterotetramer of H3 and H4, and two H2A-H2B 
dimers.  In vitro, isolated histone H3-H4 tetramers and H2A-H2B dimers can be 
reconstituted (Luger et al., 1999), and therefore it is believed that free histones in 
the cell exist in these oligomeric states.  Recent work has indicated that H3-H4 
may also exist as a heterodimeric complex under physiological conditions 
(Donham et al., 2011), although this topic remains up for debate.   
The N-terminal ʻtailsʼ of the histone proteins do not appear to make crucial 
architectural contributions to the nucleosome, but almost certainly contribute to 
higher-order chromatin assemblies (Li and Reinberg, 2011).  This function of the 
ʻtailsʼ is highly dependent on the chemical modifications of the histones within a 
single nucleosome.  Our understanding of the regulation and nature of chemical 
modifications of histone ʻtailsʼ is ever increasing, and the composition of 
14
!Figure 1-3.  Nucleosome Composition and Structure 
Figure generated with PyMol (Delano, 2002) using model PDB ID: 1kx5 (Davey 
et al., 2002) 
A) Orthogonal views of the nucleosome core particle.  Histones are depicted in a 
surface representation and colored as follows: H2A, red; H2B, green; H3, blue; 
H4, yellow.  DNA is grey and shown as a cartoon representation  
B) Models of the histone H3-H4 tetramers and H2A-H2B dimers, colored as in 






































modifications on the nucleosomes throughout a gene yields a code that can 
significantly influence the transcriptional status. 
 
 
The histone code 
 
 The residues within the N-terminal histone ʻtailsʼ can be covalently 
modified by chemical moieties such as phosphoryl, methyl, and acetyl groups, 
and can even be ubiquitylated (Jenuwein and Allis, 2001; Kouzarides, 2007; 
Strahl and Allis, 2000).  Covalent ʻtailʼ modifications can influence transcription 
and access to the underlying DNA in one of two ways, the first being the 
contributions made to higher-order chromatin assemblies (Li and Reinberg, 
2011).  The second way the chemical modification of histone tails influences 
transcription and DNA access is through the recruitment of various factors 
involved in transcription, chromatin modification, and chromatin remodeling 
(Taverna et al., 2007).  These factors utilize domains that recognize specific 
modifications and thus can interpret the ʻhistone codeʼ or the combinatorial 
manifestation of modifications present throughout the length of a given gene.  In 
the simplest explanation, acetylation is typically a transcriptional activation signal, 
while the absence of acetyl marks is generally associated with repressed 
transcription.  Overall, the common purpose of the ʻhistone codeʼ is to establish 
the chemical signatures required to coordinate the recruitment of proteins and 
protein complexes that influence DNA accessibility.  As a result, the ʻhistone 
codeʼ directly contributes to chromatin-mediated transcriptional regulation.  
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Recent work highlights the complexity of the histone code by challenging the 
notion that modifications are established in an identical, or symmetric fashion on 
both copies of each of the four core histones (Voigt et al., 2012). This work 
established that asymmetric modifications exist on mononucleosomes within 
native chromatin, and further demonstrates that asymmetric modifications signal 
different biological outcomes than symmetric modifications.    
 
 
Histone chaperones and chromatin remodelers 
 
Nucleosomes throughout the genome exist in a state of structural flux 
between fully assembled and disassembled forms (Polo and Almouzni, 2006; 
Tyler, 2002).  The balancing of this equilibrium can have dramatic consequences 
on transcription, and is mediated through the direct actions of two groups of 
proteins: Histone chaperones and chromatin remodelers.   
Histone chaperones, such as Spt6, are thought to use inherent binding 
energy to displace histones from intimate contacts with the DNA and/or prevent 
nonproductive histone-DNA contacts to allow the proper reassembly of 
nucleosomes (Andrews et al., 2010; Winkler et al., 2011).  Histone chaperones 
facilitate DNA access and maintain the integrity of chromatin throughout 
processes that perturb nucleosomal structure, such as transcription and DNA 
replication.  The inherent similarities of these processes allow many histone 
chaperones to function during each process, where they can be active in both the 
disassembly of nucleosomes in front of the respective polymerase, and 
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reassembly after passage.  The histone chaperones FACT and Asf1 have been 
shown to have physical and genetic interactions with components of the 
transcription and replication machinery (Biswas et al., 2005; Formosa, 2012; 
Formosa and Nittis, 1998; Mousson et al., 2007; Park and Luger, 2006; Rocha 
and Verreault, 2008; VanDemark et al., 2006), while other chaperones, such as 
Spt6, appear to be specific to the transcription process (Das et al., 2010; Hondele 
and Ladurner, 2011; Mello and Almouzni, 2001).   
Chromatin remodelers utilize the energy of ATP binding and hydrolysis to 
drive a motor-like ratchet system that can translocate DNA with respect to 
nucleosomal histones, or even evict histones completely (Cairns, 2005).  
Remodelers are also responsible for appropriate spacing of nucleosomes 
throughout the genome, as well as facilitating the exchange of histone variants, 
and thus contribute to both the regulation of higher-order chromatin assemblies 
and to nucleosome composition and spacing, each of which inherently impacts 
transcriptional regulation (Clapier and Cairns, 2009). 
Histone chaperones and chromatin remodelers utilize different 
mechanisms to exert their impact on chromatin integrity; however, they also 
cooperate in the precise regulatory pathways that ultimately result in 
transcriptional activation or repression (Tyler, 2002).  Spt6 is a protein that has 
an integral role in gene expression and chromatin maintenance conferred by its 
functions as a histone chaperone, transcription elongation factor, and modulator 
19
of mRNA processing.  Spt6 binds the Spn1 protein (also called Iws1) and they 
function together in many of these processes. 
 
 
The Conserved Spn1 Protein 
 
The SPN1 gene was originally identified as a key regulator of transcription 
from genes that are regulated postrecruitment of RNAPII, and is essential to 
yeast viability (Fischbeck et al., 2002). SPN1 encodes a 410 residue, 46 kDa 
protein with a central ordered core region (residues 148-295) that is flanked on 
both sides by regions predicted to be disordered (Ward et al., 2004).  
Interestingly, expression of the ordered core region complements a deletion of 
SPN1, indicating that the core provides the major function(s) of Spn1 in vivo 
(Fischbeck et al., 2002).  The ordered core of Spn1 is also highly conserved in 
sequence, and hence presumably structure, from yeast to human (Pujari et al., 
2010).  Spn1 was also identified as a protein that interacts with Spt6, and has 
been reported to bind with Spt6 in some but not all of Spt6ʼs functional states 
(Krogan et al., 2002; Lindstrom et al., 2003; Yoh et al., 2007; Zhang et al., 2008). 
For example, Spt6 can be coimmunopurified with three distinct Spt4/5-RNAPII 
complexes, whereas Spn1 is found in only two of these complexes (Lindstrom et 
al., 2003). The CYC1 gene of S. cerevisiae provides an example of how the 
Spn1-Spt6 interaction contributes to postrecruitment regulation (Zhang et al., 
2008). RNAPII is constitutively bound to the CYC1 promoter, but is kept from 
elongating because it interacts with Spn1, which in turn inhibits the Swi/Snf 
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nucleosome remodeling complex from promoting transcription. During activation, 
Spt6 binds to Spn1, and repression of Swi/Snf recruitment is relieved. 
Spn1 is also needed to achieve normal recruitment of the histone 
methyltransferase HYPB/Setd2 (Yoh et al., 2008) and the elongation factor TFIIS 
(Ling et al., 2006; Zhang et al., 2008) to RNAPII complexes traversing active 
genes.  HYPB/ Setd2 methylates histone H3K36, which in turn recruits Rpd3- 
type histone deacetylases to restore chromatin to the repressive hypoacetylated 
state and block inappropriate transcription (Yoh et al., 2008).  In contrast to their 
antagonistic relationship in activating postrecruitment initiation, Spn1 and Spt6 
each contribute toward restoration of repressive chromatin. Human Spn1/IWS1 
also binds the protein arginine methyltransferase PRMT5, which methylates the 
elongation factor Spt5 and thereby regulates its interaction with RNAPII (Liu et 
al., 2007). Spn1 can additionally function through interactions with pathway-
specific regulatory factors, such as the Arabidopsis steroid hormone responsive 
transcription factor BES1, which recruits Spn1 to the promoter and transcribed 
regions of activated genes (Li et al., 2010). Spn1 therefore contributes in several 
ways to the appropriate functioning of RNAPII. 
 
 
Spn1 and Spt6 in mRNA Processing and Export 
 
 Spt6 and Spn1 collaborate to promote the appropriate processing and 
export of mRNA molecules. Spt6 is required for proper 3ʼ-end formation by 
preventing premature 3ʼ processing at upstream polyA signals (Bucheli and 
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Buratowski, 2005; Kaplan et al., 2005).  Additionally, Spt6 binding to the Ser2-
phosphorylated RNAPII-CTD (Diebold et al., 2010; Sun et al., 2010; Yoh et al., 
2007; Yoh et al., 2008) enhances recruitment of RNA processing and export 
factors, and Drosophila Spt6 copurifies with the RNA processing exosome 
complex (Andrulis et al., 2002).  Both SPN1 and SPT6 have also been implicated 
in mRNA splicing in S. cerevisiae (Burckin et al., 2005), and binding of human 
Spn1/IWS1 to the mRNA export factor REF1/Aly is important for recruitment of 
REF1/Aly to the body of the c-Myc gene during transcription (Yoh et al., 2007).  
Further, human Spn1/IWS1 and Spt6 are required for the proper splicing of HIV-1 
transcripts, and depletion of either results in the global retention of 
polyadenylated mRNA molecules in the nucleus (Yoh et al., 2007).  Therefore, 




Spt6 is a Transcription Elongation Factor 
 
 The essential yeast protein Spt6 was originally identified in a screen for 
factors that alter normal transcription initiation (Clark-Adams and Winston, 1987; 
Denis, 1984; Neigeborn et al., 1987; Simchen et al., 1984). The role of Spt6 in 
transcription initiation has been ascribed to the ability of Spt6 to chaperone 
histones to promote reassembly of nucleosomes in the wake of RNAPII, thereby 
reestablishing the default repressive chromatin state that prevents inappropriate 
initiation of transcription (Adkins and Tyler, 2006; Bortvin and Winston, 1996; 
22
Cheung et al., 2008; Kaplan et al., 2003).  While of great importance, maintaining 
repressive chromatin appears to be just one of Spt6ʼs roles. For example, Spt6 
also enhances the elongation rate of RNAPII (Hartzog et al., 1998; Kaplan et al., 
2005; Kaplan et al., 2000; Lindstrom et al., 2003) on nucleosome-free DNA 
templates in vitro (Endoh et al., 2004; Hartzog et al., 1998; Keegan et al., 2002; 
Yoh et al., 2007), as well as on chromatin templates in vivo (Ardehali et al., 
2009). Spt6 is also classified as a transcription elongation factor because it 
colocalizes with RNAPII in Drosophila at sites of active transcription (Andrulis et 
al., 2000; Kaplan et al., 2000; Zobeck et al., 2010), and can be coimmunopurified 
with RNAPII throughout the length of an actively transcribed gene, indicative of a 
factor that travels along with the transcription elongation complex (Mayer et al., 
2010). Together, these data indicate that Spt6 plays a number of mechanistically 
distinct roles during transcription. 
 
 
Spt6 is a Histone Chaperone 
 
 The histone chaperone activity of Spt6 is necessary to maintain the 
integrity of chromatin to prevent spurious transcription from repressed promoters 
and cryptic intragenic transcription start sites (Adkins and Tyler, 2006; Cheung et 
al., 2008; Kaplan et al., 2003).  Spt6 appears to exert this function through direct 
interactions with histones, with an apparent preference for the histone H3-H4 
tetramer, and it promotes the deposition of histones and presumably the 
assembly of nucleosomes on plasmid DNA (Bortvin and Winston, 1996).  The 
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PHO5 promoter provides an example of Spt6ʼs role in nucleosome reassembly 
upon repression of transcription (Adkins and Tyler, 2006).  Under high 
intracellular phosphate conditions, the transcriptional activator Pho4 is retained in 
the cytoplasm and transcription from PHO5 is repressed.  In low phosphate 
conditions, Pho4 is translocated to the nucleus where it binds the PHO5 promoter 
and activates transcription.  Nucleosome disassembly from the PHO5 promoter, 
which is essential for transcriptional activation, is mediated by the histone 
chaperone Asf1 (Adkins et al., 2004; Adkins et al., 2007).  Nucleosome 
reassembly at the PHO5 promoter, which is required to repress transcription, is 
mediated by Spt6 (Adkins and Tyler, 2006).  Surprisingly, SPT6 mutants that are 
defective in nucleosome reassembly not only fail to repress PHO5 transcription, 
but also allow transcriptional reactivation in the absence of the activator Pho4.  
Spt6 appears to perform this same function at other inducible genes, such as 
PHO8, ADH2, ADY2, and SUC2.  Spt6 is also required for nucleosome 
reassembly throughout the open reading frame (ORF) of PHO5, and prevents 
transcription initiation from a cryptic transcription start site in the constitutively 
active FLO8 gene (Cheung et al., 2008; Kaplan et al., 2003).  Overall, these data 
indicate an extensive role for Spt6 in promoting nucleosome reassembly at 
promoters and within ORFs of inducible and constitutively active genes to 




Goals of this Dissertation 
 
 Spt6 and Spn1 are transcription factors that bind one another and are 
each essential for yeast viability.  Spt6 functions as a histone chaperone, a 
transcription elongation factor, and corroborates with Spn1 in mRNA processing 
(Figure 1-4).  Although the importance of Spt6 and Spn1 in these processes is 
clear, little is known of the precise mechanistic details for any of their proposed 
functions.  Therefore, the overall goal of this dissertation is to examine the 
molecular details of the functions of Spt6 and Spn1.  The primary objectives were 
to structurally characterize Spt6, to describe the Spn1-Spt6 interaction 
structurally, biochemically, and genetically, and to perform a biochemical 
characterization of the Spt6 histone chaperone activity.  The structures and 
functional data described in this dissertation have enhanced our understanding of 
how Spt6 binds and chaperones histones, and describes a novel role for Spn1 in 
regulating the histone chaperone activity of Spt6.   The Spt6 and Spn1 structures 
and the biochemical assays developed in this work will aid in future functional 
and mechanistic studies aimed at developing a complete molecular and 




!Figure 1-4.  Overview of the Functional Roles of Spt6 and Spn1 
Figure made by Devin Close, used with permission. 
The multifaceted Spt6 protein is a histone chaperone, transcription 
elongation factor, and collaborates with its binding partner Spn1 to recruit 
factors required for proper mRNA processing and export.   
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Outline of Chapters 
 
Chapter 2: Crystal Structures of the S. cerevisiae Spt6 Core  
and C-Terminal Tandem SH2 Domain (D. Close, et al.) 
 The work described in Chapter 2 was originally published in the May 13, 
2011 issue of Journal of Molecular Biology and is reprinted here in the published 
format.  The focus of this work was to structurally characterize the yeast Spt6 
protein, to investigate the Spt6 nucleic acid binding activity, and determine 
specificity for the C-terminal tandem SH2 domain in binding to phospho-isoforms 
of peptides mimicking the RNAPII-CTD.   
 The work in this chapter was initiated by Sean Johnson, a former postdoc 
in the lab, who solved the 3.3 Å resolution structure of the Spt6 core.  Devin 
Close took that aspect of the project to completion and solved the higher 
resolution structures of the Spt6 core, as well as the structure of the C-terminal 
tSH2 domain.  Devin was also critical in developing the nucleic acid and peptide 
binding assays used in the paper.  I performed some of the cloning of the tSH2 
domain mutants, and Matt Sdano and I helped to complete the peptide binding 
assays.  One of my goals was to demonstrate nucleic acid binding specificity by 
mutational analysis of the (HhH)2 domain, which ultimately proved unsuccessful.  
Overall, the structural and biochemical analysis of Spt6 presented in this chapter 
provide an invaluable foundation to further our understanding of Spt6 function, 
and helped to guide the structural and biochemical studies presented in Chapters 
3, 4, and 5. 
28
Chapter 3: Structure and Biological Importance of the Spn1-Spt6  
Interaction, and its Regulatory Role in Nucleosome  
Binding (S.M. McDonald and D. Close, et al.) 
 The work described in Chapter 3 was originally published in the December 
10, 2010 issue of Molecular Cell and is reprinted here in published format.  The 
focus of this work was the structural, biochemical, and genetic characterization 
the Spn1-Spt6 interaction.  We determined crystal structures of the ordered core 
region of Spn1 alone and in complex with the binding determinant of Spt6.  
Mutating interface residues greatly diminished binding in vitro and caused strong 
phenotypes in vivo, including a defect in maintaining repressive chromatin.  
Nucleosome binding by Spt6 was disrupted in the presence of Spn1, revealing a 
potential role for Spn1 in regulation of the histone chaperone activity of Spt6.   
 The work in this chapter was performed in close collaboration with Devin 
Close and Hua Xin.  Devin and I worked together to solve the Spn1 structure and 
the structure of the Spn1-Spt6 complex, while I performed all of the biochemical 
experiments examining the Spn1-Spt6 interaction.  Members in the lab of our 
collaborator Tim Formosa, especially Hua Xin, performed all of the genetic 
experiments and the nucleosome binding assays.  Overall, our results point to a 
novel function for Spn1 in regulating the histone chaperone activity of Spt6, and 
provide a structural foundation for future work investigating the mechanism of 
Spn1 functions.  This work also provided significant impetus for the work 
presented in Chapter 4.   
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Chapter 4: Mechanism of Histone Chaperone Activity  
of Spt6 and its Regulation by Spn1 
 Work in this chapter describes the biochemical analysis of the direct 
interactions between Spt6 and the two nucleosomal histone subcomplexes, H2A-
H2B dimers and H3-H4 tetramers [(H3-H4)2].  We further demonstrate that the 
Spn1-Spt6 and the Spt6-(H3-H4)2 interactions are mutually exclusive, and that 
Spt6 competes with DNA for (H3-H4)2 binding.  These observations lead us to 
propose a direct-competition mechanism for the histone chaperone activity of 
Spt6, and strongly support a role for Spn1 as a regulatory switch in this process.  
We also determined that the mode of interaction between Spt6 and each of the 
two histone subcomplexes appears to be different, with only the interaction with 
H2A-H2B being highly sensitive to elevated salt concentrations.  Further, Spt6 
appears to bind the ordered core of the histone subcomplexes with the same 30 
residue N-terminal segment that is required for Spn1 binding.   
 The work in this chapter was initiated by Devin Close, who aided in the 
development of the fluorescence anisotropy assay used to quantify binding to 
histones, while I performed all of the assays presented here.  Overall, the data 
presented in this chapter strongly support our previous hypothesis that Spn1 
plays a regulatory role in the histone chaperone activity of Spt6, and suggest a 




Chapter 5: Conclusions and Ongoing Research 
  Chapter 5 summarizes the structural and biochemical work presented in 
Chapters 2, 3, and 4, and discusses the functional implications for Spn1 and 
Spt6.  In addition, this chapter describes preliminary structural studies on the 
Spt6-H2A-H2B complex, and the development of a small-scale proteomics 
approach to identifying new Spn1 and Spt6 binding partners.  Preliminary 
structural studies on the Spt6-H2A-H2B complex, which are being undertaken in 
close collaboration with Matt Sdano, have yielded protein-containing crystals that 
diffract to low (~7 Å) resolution.  Matt also developed the small-scale proteomics 
approach and initial results reveal interactions between the Spt6 C-terminal 
domain and several factors involved in transcription, including Yra1, an mRNA 
export adaptor protein, and Tom1, an E3-ubiquitin ligase of the HECT-class that 
is important for mRNA export and excess histone degradation.  Long-term goals 
include structural, biochemical, and genetic characterization of confirmed direct 
binding partners.  Overall, the work in this chapter, combined with the structural 
and functional data presented in the rest of the dissertation, provides a 
foundation for future work aimed at assessing molecular details of the proposed 
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The conserved and essential eukaryotic protein Spt6 functions in
transcription elongation, chromatin maintenance, and RNA processing.
Spt6 has three characterized functions. It is a histone chaperone capable of
reassembling nucleosomes, a central component of transcription elongation
complexes, and is required for recruitment of RNA processing factors to
elongating RNA polymerase II (RNAPII). Here, we report multiple crystal
structures of the 168-kDa Spt6 protein from Saccharomyces cerevisiae that
together represent essentially all of the ordered sequence. Our two
structures of the ∼900-residue core region reveal a series of putative nucleic
acid and protein–protein interaction domains that fold into an elongated
form that resembles the bacterial protein Tex. The similarity to a bacterial
transcription factor suggests that the core domain performs nucleosome-
independent activities, and as with Tex, we find that Spt6 binds DNA.
Unlike Tex, however, the Spt6 S1 domain does not contribute to this
activity. Crystal structures of the Spt6 C-terminal region reveal a tandem
SH2 domain structure composed of two closely associated SH2 folds. One of
these SH2 folds is cryptic, while the other shares striking structural
similarity with metazoan SH2 domains and possesses structural features
associated with the ability to bind phosphorylated substrates including
phosphotyrosine. Binding studies with phosphopeptides that mimic the
RNAPII C-terminal domain revealed affinities typical of other RNAPII
C-terminal domain-binding proteins but did not indicate a specific
interaction. Overall, these findings provide a structural foundation for
understanding how Spt6 encodes several distinct functions within a
single polypeptide chain.
© 2011 Elsevier Ltd. All rights reserved.
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Introduction
Gene expression in eukaryotes relies on a syner-
gistic relationship between transcription, RNA
processing, and chromatin structure.1,2 The specific
positioning, composition, and posttranslational
modification of nucleosomes defines a code for
chromatin-templated transcriptional regulation.
Moreover, transcription is intimately tied to
mRNA processing, surveillance, and export from
the nucleus. This coordination relies on precise
cooperation among many proteins, with Spt6
being remarkable for playing multifaceted roles in
several distinct processes.
Spt6 (suppressor of Ty 6) was originally discov-
ered in Saccharomyces cerevisiae as a gene that
influences general transcription through manipula-
tion of chromatin structure at upstream promoter
elements.3 Subsequently, Spt6 has been implicated
in a variety of biological processes in organisms
ranging from yeasts to human, including embryo-
genesis in zebrafish,4 multiple stages of develop-
ment in Drosophila,5gut morphogenesis in
Caenorhabditis elegans,6 signal transduction in
mammals,7,8 and pathogenesis of human immuno-
deficiency virus.9,10 The broad utility of Spt6 stems
from its ability to perform multiple functions as a
histone chaperone, a transcription elongation factor,
and a modulator of RNA transcript processing.
Spt6 is required for reassembly of nucleosomes in
the wake of an elongating RNA polymerase II
(RNAPII), a function that has profound regulatory
effects at both intergenic and intragenic start
sites.11,12 Spt6 binds directly to histones and
nucleosomes in vitro,13,14 and these activities may
contribute to the nucleosome reassembly function.
In addition, Spt6 recruits the H3K36 methyltransfer-
ase Set2 to the transcription complex,15 providing a
link between the processes of transcription and
histone modification. While its roles in modifying
and reassembling nucleosomes indirectly influence
the elongation rate, Spt6 also directly affects
RNAPII, as it stimulates elongation on nucleo-
some-free DNA templates in vitro.9,16 This role as
an elongation factor independent of its effects on
chromatin may also be significant in vivo, as knock-
ing down Spt6 caused a decrease in the RNAPII
elongation rate even in regions where the chromatin
was considered to be permissive to transcription.16
Yet another role as a modulator of transcript
processing is indicated by the association of Spt6
with the Rrp6 subunit of the Drosophila exosome
RNA processing complex17 and by the requirement
for Spt6 to prevent premature 3′ processing at
cryptic polyadenylation signals upstream of the
appropriate sites.18 It has also been demonstrated
that mammalian Spt6 can bind RNAPII C-terminal
domain (CTD) phosphorylated at Ser2 by the P-
TEFb kinase and that this interaction can subse-
quently promote recruitment of RNA processing/
export factors such as REF1/Aly.9,15 Binding to the
phosphorylated RNAPII CTD is mediated by a Src
homology 2 (SH2) domain that is located near the
C-terminus of Spt6 and is conserved from yeast to
human.9 SH2 domains typically recognize phos-
phorylated tyrosine residues, are ubiquitous in
metazoans, and are the primary recognition motif
in phosphorylation-mediated signal transduction
cascades.19 Strikingly, the Spt6 SH2 domain is the
only SH2 domain predicted to occur in the yeast
Fig. 1. Spt6 structures. (a) Schematic representation of
full-length (top) Spt6 and constructs used for crystalliza-
tion. The three crystallized constructs (239–1451, 236–
1259, and 1247–1451) are shown below, with black
continuous lines indicating regions of the protein con-
structs visible in each of the crystal structures. (b) Three
independently determined Spt6 crystal structures colored
by domain as in (a).
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proteome.20 Spt6 therefore participates in a wide
range of functions affecting transcription, with each
activity requiring different subsets of its multiple
distinct functional domains.
We have determined multiple crystal structures of
Spt6 fromS. cerevisiaeand find that, consistentwith the
range of functional domains inferred from previous
studies, it comprises a series of structural domains
whose homologs are known to function in nucleic acid
binding and/or protein–protein interactions. The core
of the structure comprises several recognizable
structural motifs and, in composite, resembles the
bacterial transcription factor Tex.21 A C-terminal
region that is tethered to the core by a flexible linker
adopts a novel tandem SH2 domain comprising two
closely associated SH2 folds, one of which corre-
sponds to the previously predicted SH2 domain of
Spt6 and contains many of the standard binding
determinants characteristic of this family, while the
other lacks these features but contributes to a putative
specificity pocket of the more canonical SH2 domain.
Our structure of the Spt6 tandem SH2 domain
resembles two recently reported homologous Spt6
structures.22,23 We also show that the Spt6 core
domain has DNA-binding activity, and we examine
the interaction between the Spt6 tandem SH2 domain
and RNAPII-derived peptides for evidence of a
phosphorylation-dependent interactionwith theCTD.
Results and Discussion
Crystal structures of Spt6(236–1259),
Spt6(239–1451), and Spt6(1247–1451)
We have determined three crystal structures that
together comprise the entire ordered region of the
1451-residue S. cerevisiae Spt6 protein (Figs. 1–3).
Based on these structures and sequence analysis,
Spt6 residues 1–297, 456–464, 485–500, 562–566,
1003–1008, 1211–1217, and 1441–1451 are likely to
Fig. 2. Composite model of Spt6. (a) Schematic model of the Spt6 protein as in Fig. 1a. Black bar indicates segments of
the protein represented by the composite model. (b) Two views of the composite model of Spt6 colored by domain.
Approximately two hundred C-terminal residues (tSH2 domain) are expected to be highly mobile with respect to the core.
Secondary structure elements mentioned in the text are labeled. Broken lines represent regions of the Spt6 protein that are
not visible in our structures and are likely to be disordered, including the first 297 residues. (c) Composite model of Spt6
colored from the N- to C-terminus (blue to red). View orientation is rotated 180° from that of the lower image in (b).
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be disordered in the full-length protein, at least in
the absence of binding partners. Spt6 displays
multiple recognizable structural domains whose
homologs have been implicated in binding of
nucleic acids or proteins, although conservation at
the sequence level is low, and only three of these
domains [(HhH)2, YqgF, and S1] in the Spt6 core
were predicted from the sequence.25
Full-length Spt6 expressed poorly inEscherichia coli
and did not yield crystals. In contrast, two different
Spt6 constructs that lacked the first ∼235 residues
and either lacked the C-terminal 192 residues [Spt6
(236–1259)] or extended to the C-terminus [Spt6
(239–1451)] expressed well, and the resulting
proteins crystallized in different space groups
(Table 1). The Spt6(236–1259) structure was deter-
mined by two-wavelength anomalous diffraction
using data collected to 2.7 Å from crystals of
selenomethionine-substituted (SeMet) protein and
was refined against 2.6-Å native data to R/Rfree
values of 22.4%/26.5%. The Spt6(239–1451) struc-
ture was determined by molecular replacement
using the Spt6(236–1259) structure as a search
model and refined against 3.3-Å data to R/Rfree
values of 26.5%/30.8%.
Together, Spt6(236–1259) and Spt6(239–1451) dis-
play an ordered structure for the Spt6 core (residues
298–1248), which is primarily helical (54.6% helical,
8.3% strand, 37.1% coil), has overall dimensions of
110 Å×77 Å×36 Å, and is quite similar between the
two structures (RMSD=1.2 Å over 747 out of 763
pairs of Cα atoms that are ordered in both
structures). The core is built around an ∼80-Å-long
central helix (H21, 680–733), with the rest of the
Fig. 3. Spt6 sequence. Spt6 sequence present in the composite model with corresponding secondary structure elements
colored by domain as in Figs. 1 and 2. Coloring of sequence represents degree of conservation [dark-red background,
invariant; orange font, conserved] in an alignment (see Supplemental Fig. S1) of proteins from S. cerevisiae,
Schizosaccharomyces pombe, C. elegans, Drosophila melanogaster, Danio rerio, and Homo sapiens. Alignment was performed
using T-coffee.24 Broken lines indicate regions of disorder that are not included in the model(s).
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protein chain wrapping around this helix at both
ends to give an overall V shape. Additionally, Spt6
(239–1451) displayed interpretable density for the S1
domain (residues 1128–1210), whereas the
corresponding density in Spt6(236–1259) was poorly
defined, and the S1 domain was not included in this
refined structure. As discussed below, we favor a
model in which the S1 domain is highly mobile in
solution. Interestingly, the 240 C-terminal residues
of Spt6(239–1451), encompassing all of the residues
absent from the shorter Spt6(236–1259) construct,
are not visible in the electron density. The Spt6(239–
1451) crystals have an estimated solvent content of
60% with cavities that could accommodate the
240 C-terminal residues, which suggests that this
region is tethered by a flexible linker that is mobile
both in solution and in the Spt6(239–1451) crystals.
Guided by secondary structure predictions and
limited proteolysis experiments (data not shown), we
expressed and crystallized the Spt6C-terminal region,
Spt6(1247–1451). This structure was determined by
the selenomethionine single-wavelength anomalous
diffraction method using 2.7-Å-resolution data and
refined to R/Rfree values of 20.7%/25.4%. A second
native crystal form yielded 2.1-Å-resolution data,
and this model was refined to R/Rfree values of
17.9%/21.2%. The SeMet and native proteins crystal-
lized in different space groups with one and four
molecules in the asymmetric unit, respectively
(Table 2). Surprisingly, we found that the Spt6
C-terminal region comprises not one SH2 domain
as anticipated,20,28 but two SH2 folds that are
packed tightly against each other to form a tandem
SH2 domain composed of N-terminal (nSH2,
residues 1250–1353) and C-terminal (cSH2, residues
1354–1440) folds. While this manuscript was in the
final stages of preparation, equivalent tSH2 struc-
tures that overlap closely with our refined
model were reported for Spt6 homologs from
Candida glabrata22 (RMSD=1.0 Å over 184 Cα
atoms with 87% sequence identity) and Antonospora
locustae23 (RMSD=1.6 Å over 164 Cα atoms with
24% sequence identity).
N-terminal region
The first ∼300 amino acids of Spt6 are extremely
acidic, with an overall charge of −62 and a predicted
pI of 4.3, and are also predicted to be disordered.29
This is consistent with our Spt6(236–1259) and Spt6
(239–1451) structures, which lacked discernible
density prior to residue 298. Despite the lack of
inherent order, this region of Spt6 is functionally
important. Residues 239–268 bind the essential
Spn1/Iws1 protein and overlap with residues
required for nucleosome binding.14 Furthermore,
the spt6-1002 allele, a deletion of residues 2–122,
displays synthetic lethality with deletion of the gene
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Helix–turn–helix domain
Residues 336–442 resemble a DNA-binding helix–
turn–helix (HtH) motif, as seen in transcription
factors such as c-Myb and the bacterial sigma
factors.30 Nevertheless, the structure is not consis-
tent with binding DNA in a canonical manner;
binding of Spt6 H7 in the major groove of DNA in
the manner predicted for a canonical HtH domain
would cause steric clashes between bound DNA and
the rest of the structure. It is possible that Spt6
undergoes conformational changes upon binding
DNA or that the Spt6 HtH domain serves as a
protein–protein interaction motif, as occurs with
members of the PWI subgroup of HtH domains.31
The Spt6 HtH overlaps with the U4/U6 ribonucleo-
protein Prp3 PWI domain [RMSD of 2.7 Å, 69 Cα,
Protein Data Bank (PDB) code 1x4q] and the Nab2
PWI domain (RMSD of 2.9 Å, 73 Cα, PDB code
2v75), conserves the eponymous PWI motif as NWI
(Asn349-Trp350-Ile351), and could utilize the equiv-
alent protein-binding surface without invoking a
conformational change in Spt6.
YqgF homologous domain
The Spt6 YqgF domain (residues 735–887) resem-
bles members of the YqgFc superfamily, such as the
E. coli protein YqgF and the RuvC class of Holliday
junction resolvases.25 The alignment is especially
close with E. coli RuvC (RMSD of 2.9 Å, 117 Cα, PDB
code 1hjr). Despite this similarity, the putative Spt6
YqgF catalytic site lacks carboxylate side chains
that are critical for coordinating magnesium ions











Space group P212121 P212121 P3121 I4122 P212121
Unit cell dimensions (Å) a=114.0 a=115.1 a=118.7 a=97.5 a=78.8
b=116.4 b=116.2 b=118.7 b=97.5 b=105.2
c=122.7 c=117.4 c=214.4 c=132.4 c=119.5
Molecules per
asymmetric unit
1 1 1 1 4
Solvent content (%) 63.7 62.4 60.0 63.5 53.1
Beamlinea SSRL 11-1 SSRL 11-1 SSRL 7-1 NSLS X29 SSRL 9-1 Home
Wavelength (Å) 0.97886 0.97922 0.97773 1.10000 0.97908 1.54178
Resolution (Å) 50–2.7 50–2.7 32–2.6 46–3.3 35–2.7 30–2.1
High-resolution shell (Å) (2.8–2.7) (2.8–2.7) (2.7–2.6) (3.42–3.3) (2.8–2.7) (2.18–2.1)
No. of unique
reflections
83,751 82,946 49,595 27,025 8481 58,489
No. of total
reflections
261,886 257,334 434,557 182,336 649,419 258,498
Mean I/σI 22.1 (2.4) 22.1 (2.1) 29.8 (4.3) 39.8 (3.3) 25.1 (3.7) 16.8 (3.2)
Completeness (%) 95.8 (75.8) 94.7 (70.1) 99.8 (99.9) 99.5 (99.9) 92.2 (74.5) 99.5 (99.2)
Rsym (%)b 4.8 (35.7) 4.7 (38.3) 6.5 (43.9) 5.8 (56.9) 7.0 (29.6) 6.6 (47.8)
Refinement
Rcryst c/Rfreed (%) 22.4/26.5 26.5/30.8 20.7/25.4 17.9/21.2
No. of non-H atoms
Protein 6788 6876 1575 6988
Solvent 48 0 19 491
〈B〉 (Å2) 103.7 167.6 74.7 44.2
RMSD bond
lengths (Å)
0.006 0.013 0.008 0.004
RMSD bond angles (°) 0.895 1.59 1.12 0.757
Ramachandran
outliers (%)
0.0 0.8 0.0 0.40
Ramachandran
favored (%)
95.6 93.6 97.9 97.5
Rotamer outliers (%) 0.94 0.3 0.6 1.4
Values in parentheses correspond to the high-resolution shell.
Refinement statistics were determined by PHENIX26 and MolProbity.27
a Data were collected at the SSRL, the NSLS, or on a RigakuMicroMax-007HF rotating anode X-ray generator with a copper anode and
VariMax confocal optics and a Rigaku R-AXIS IV image plate detector (home).
b Rsym=(∑|(I− 〈I〉)|)/(∑I), where 〈I〉 is the average intensity of multiple measurements.
c Rcryst= (∑|Fobs−Fcalc|)/(∑|Fobs|).
d Rfree is the Rcryst based on ∼1000 (at least 10%) of the reflections that were excluded from refinement.
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that mediate phosphodiester bond hydrolytic
cleavage.32 Thus, it does not appear that the Spt6
YqgF fold is capable of nuclease activity using a
catalytic mechanism similar to that of RuvC or
related RNase H-fold nucleases.
Helix–hairpin–helix domain
Residues 933–1002 form two consecutive helix–
hairpin–helix (HhH) motifs that pack together
through highly conserved hydrophobic residues at
an ∼90° angle to form a (HhH)2 domain that
resembles known double-stranded DNA (dsDNA)
binding domains.33 These include proteins such as
E. coli RNA polymerase α CTD (RMSD of 2.3 Å, 56
Cα, PDB code 1lb2) and the Holliday junction-
binding protein RuvA (RMSD of 2.2 Å, 60 Cα, PDB
code 1bvs). The first Spt6 HhH represents a
characteristic HhH motif in the relative angle of
the antiparallel helices and the presence of the Gly-
hydrophobic-Gly motif within the hairpin loop.33
The second HhH motif is more variant, as also
observed in other (HhH)2 domains, including DNA
polymerase β and 5′ to 3′ exonucleases. Though
Fig. 4. The most conserved surface of the Spt6 core. (a) View of the Spt6 core showing the interface between HtH, DLD,
and (HhH)2 domains. (b) Same orientation as (a) but colored by conservation to illustrate the high level of surface
conservation at the intersection of these domains, especially on the DLD. Coloring represents degree of conservation as
described in Fig. 3 and Supplemental Fig. S1. (c) Same as (b) but colored by electrostatic potential (−5 to +5 kT/e).
Fig. 5. Surface representations of the Spt6 and Tex S1 domains. (a) Electrostatic surface representation (−5 to +5 kT/e)
of the S1 domain from Pseudomonas aeruginosa Tex (PDB code 3bzk) with the position of the nucleic acid binding OB-fold
cleft approximated by the circle with the dotted green line. (b) Electrostatic surface representation (−5 to +5 kT/e) of the S.
cerevisiae Spt6 S1 domain in the same orientation as in (a) showing a clustering of negative charge in the putative OB-fold
binding cleft. (c) S. cerevisiae Spt6 S1 domain in the same orientation as (b) but colored by conservation in the same color
scheme as in Fig. 3 to illustrate the low level of conservation within the region equivalent to the binding cleft of canonical
S1 domains.
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(HhH)2 folds are primarily found in proteins that
interact with DNA, they also occur in proteins that
mediate protein–protein interactions, such as the
sterile α motif proteins.34 Notably, the first 28
ordered residues (∼298–325) of Spt6 wrap around
the (HhH)2 domain in a fashion that would occlude
binding of a canonical (HhH)2 domain to a dsDNA
ligand, although this interaction could be transient.
The absence of corresponding density for H1 and
part of H2 in the initial SeMet Spt6(236–1259) and
Spt6(239–1451) maps suggests that these N-terminal
residues might adopt a different conformation to
allow binding of a physiological partner in vivo.
Death-like domain
Residues 1019–1104 form a prominent lobe of the
structure that resembles members of the death
domain superfamily. Death domains typically
serve as recognition modules in proteins that
assemble and activate inflammatory and apoptotic
complexes.35 The Spt6 death-like domain (DLD)
maintains the characteristic overall topology of
death domains, consisting of a six-helix bundle
with three stacked antiparallel helices but with an
additional helix inserted between the final two
helices of the bundle (H39 in Figs. 2 and 3). Spt6
aligns reasonably well with several known death
domain superfamily proteins, including the caspase-
2-activating PIDDosome PIDD protein subunit
component (RMSD of 3.0 Å, 60 Cα, PDB code
2of5). Although it is unlikely that the Spt6 DLD
functions in an apoptotic process in yeast, its
prominent location and the observation that it
displays the most highly conserved region of the
Spt6 surface suggest that it mediates important
intermolecular interactions (Fig. 4).
S1 domain
A mostly unstructured linker of 15 residues leads
to the S1 domain (residues 1129–1219), which adopts
the canonical S1/oligonucleotide–oligosaccharide
binding (OB)-fold of a β-barrel composed of two
three-stranded β-sheets where strand 1 (S10) is
shared by both sheets.36 Despite the structural
similarity, Spt6 lacks the typical S1 binding cleft
residues that are important for binding nucleic
acids.36 In addition, the predicted electrostatic
potential surface does not appear conducive to
nucleic acid binding, shows a low level of conser-
vation, and, as discussed below, is not required for
dsDNA binding (Fig. 5). This is in contrast to the
distantly related bacterial Tex protein, which loses
its capacity to bind DNA or RNA in the absence of
the S1 domain.21 OB folds are used to bind partners
other than nucleic acids, including oligosaccharides
and proteins;36,37 thus, it remains possible that the
Spt6 S1 domain is used for an important interaction
that does not involve nucleic acids.
Tandem SH2 domain
The S1 domain is followed by an unstructured
∼10-residue segment and an ∼30-Å helix (H44;
1227–1247) that buries ∼440 Å2 of accessible surface
area against the core in the Spt6(236–1259) structure
(Fig. 2). While some density is present for H44 in the
Fig. 6. The S. cerevisiae Spt6 tSH2 domain. (a) Two views of a cartoon representation of the tSH2 domain colored from
the N- to C-terminus (blue to red; residues 1247–1440 are shown). Dotted squares and circles show the approximate
positions of the canonical SH2 domain pTyr and specificity pockets, respectively. (b) Surface representation colored by
electrostatic potential surface (−5 to +5 kT/e). (c) Same as (b) but colored by residue conservation in the same color
scheme as in Figs. 3 and 4.
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Spt6(239–1451) maps, this region is too disordered
for reliable model building, which may indicate that
this interface is not always formed in solution. H44
links the core to a tandem SH2 domain (tSH2;
residues 1250–1440) that comprises N-terminal
(nSH2; residues 1250–1353) and C-terminal (cSH2;
1353–1440) folds that associate through an ∼800-Å2
interface to form a single structural unit (Fig. 6). Both
nSH2 and cSH2 conform to the standard SH2
domain fold (standard SH2 nomenclature in paren-
thesis) of an N-terminal helix (αA), a central three-
stranded β-sheet (βB–βD), a small two-strand
extension to the β-sheet (βE–βF), and a second
helix (αB).38 Intervening loops are labeled based on
their relative position between these elements (e.g.,
the BC loop connects the βB and βC strands). The
Spt6 nSH2 and cSH2 superimpose well with each
other (RMSD of 2.1 Å, 69 Cα; Fig. 7) and with the
multitude of other characterized SH2 domains, such
as those from v-Src kinase (nSH2: RMSD of 2.0 Å, 82
Cα; cSH2: RMSD of 2.1 Å, 80 Cα, PDB code 1sps;
Fig. 7) and Nck2 (nSH2: RMSD of 2.1 Å, 83 Cα; cSH2:
RMSD of 1.9 Å, 73 Cα, PDB code 2cia).
The relative orientation of the two SH2 folds that
comprise the Spt6 tSH2 domain is unlike that of
previously reported tandem SH2 domains from
Fig. 7. tSH2 binding pockets. (a) Overlay of Spt6 nSH2 (orange) and the v-Src Kinase SH2 domain (green; PDB code
1sps) bound to a pTyr ligand (yellow). Secondary structure elements are labeled based on the standard SH2
nomenclature.38 (b) Detailed view of the pTyr binding pocket of 1sps. Residues contributing to the coordination of the
pTyr ligand are shown. (c) Same as (b) but for the Spt6 nSH2, with the pTyr peptide from 1sps positioned after the overlap
on the SH2 protein domains. (d) Electron density for a sulfate bound in the tSH2 crystal structures. Blue density represents
the 2mFo−DFc map contoured at 2.0 σ, and green density represents an anomalous difference Fourier map contoured at
3.0 σ. (e) The putative nSH2 specificity pocket. Residues from both nSH2 (orange) and cSH2 (olive) line the nSH2
specificity pocket. (f) Alignment of the Spt6 nSH2 (orange) and cSH2 (olive) folds. Residues that protrude into the typical
location of the pTyr binding pocket of the cSH2 fold are shown.
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other proteins. The αB helix of nSH2 undergoes an
∼20° kink where the αB helix would end in a
canonical SH2 domain and extends along the
backside of the cSH2 fold to form an extensive
hydrophobic packing interface with the cSH2
central β-sheet. The relative orientation of nSH2
and cSH2 folds therefore appears to be constrained,
consistent with the observation that superposition of
the five crystallographically independent tSH2
domains observed in our various crystal forms
[one in SeMet Spt6(1247–1451) and four in native
Spt6(1247–1451)] indicates a maximum relative
rotation of ∼8° between nSH2 and cSH2 folds.
Implications for ligand binding by the
tSH2 domain
The extent to which Spt6 nSH2 corresponds to a
prototypic SH2 domain is seen in a comparison with
v-Src (PDB code 1sps) (Fig. 7a–c). The primary
determinants of phosphate binding are preserved in
nSH2, whereas the positively charged Arg/Lys side
chains of classical SH2 domains that flank the
aromatic ring of phosphotyrosine (pTyr) ligands
are absent from their usual positions. Conserved
residues include the consensus FLVRES (FVIRQS,
1279–1284 in Spt6) sequence motif that contributes
the phosphate-coordinating Arg1282 and Ser1284
side chains (Spt6 numbering). Moreover, the follow-
ing Ser1285 Spt6 side chain is also well positioned to
hydrogen bond the phosphate and functionally
substitute the ThrBC2 of the Src SH2 domain.
Other positions within SH2 domains that are
important for binding phosphate include HisβD4
(Spt6 H1304) and Ser/ThrβC4 (Spt6 Thr1294),
whose side chains hydrogen bond the Arg1282 side
chain in an optimum orientation for phosphate
binding and, in cognate SH2–ligand complexes,
also form a main chain to main chain hydrogen
bond with the ligand residue following the pTyr.
Classical SH2 domains typically have a basic
residue at the αA2 position that binds against one
side of the tyrosine ligand aromatic ring where it
forms an amino–aromatic interaction with the pi ring
and also hydrogen bonds with both the phosphate
and the tyrosine main-chain carbonyl. In contrast,
the Spt6 nSH2 has a glycine at this position, G1264,
which can make none of the same ligand interac-
tions. This does not argue strongly against binding
of pTyr by Spt6, however, because a number of
other SH2 domains that bind pTyr ligands have a
variety of substitutions at this position, including
the PTPN11/SHPTP2/Syp phosphatase (PDB code
1ayc) that, like Spt6, has a Gly at αA2 and is known
to bind a pTyr-containing peptide.39 On the other
side of a canonical pTyr ligand side chain, classical
SH2 domains typically have a basic residue in the
βD6 position. This residue is a lysine in Src but is an
aspartate (D1306) in Spt6. Interestingly, in three of
the five crystallographically independent Spt6 tSH2
molecules in our structures, the space typically
occupied by the basic βD6 side chain is filled by
R1286 in the BC3 position (Fig. 7c). Thus, Spt6
retains the ability to provide a positively charged
basic group in this position, consistent with the
potential to bind pTyr.
Ammonium sulfate was present in the crystalliza-
tion solutions for both native and SeMet tSH2
domain structures, and all five crystallographically
independent molecules displayed a sulfate ion at the
putative nSH2 phosphate binding site, where it
forms hydrogen bonds with R1282, S1284, and S1285
in the same manner as the phosphate of pTyr–SH2
complexes (Fig. 7d). Assignment of the density as
sulfate was confirmed in anomalous difference
Fourier maps for the native data, which showed
peaks that were similar in size to those of cysteine
andmethionine sulfur atoms for some of the sulfates.
This further suggests that nSH2 binds a phosphor-
ylated ligand and that it might accommodate a pTyr
side chain in a suboptimal binding pocket.
Typical SH2 domain ligands bind through a two-
prong mechanism that, in addition to binding pTyr,
also involves binding of the three side-chain
residues C-terminal to the pTyr into the “specificity
pocket.”38 Binding partner preference is typically
defined in the specificity pocket by the BG and EF
loops and the βD3 and βD5 residues, which usually
favor binding of hydrophobic residues. In contrast,
the Spt6 nSH2 fold predominantly displays charged
and polar residues in this site, and there is no BG
loop due to the extension of nSH2 αB to the cSH2
fold. Instead, cSH2 residues such as the DE loop and
a βD side chain (K1411) protrude into the pocket,
forming the top portion of the nSH2 specificity
pocket (Fig. 7e). This indicates that, if the nSH2 fold
binds substrate in the typical “two-pronged” man-
ner common to SH2 domains, the cSH2 fold would
make significant contributions to binding.
In contrast to nSH2, the cSH2 fold appears to be
cryptic and unlikely to bind a phosphorylated
ligand because residues critical for phosphate
binding are substituted to display a very different
chemical environment, and the Y1394 side chain fills
the space where a phosphate would typically bind
(Fig. 7f). Moreover, the region of the specificity
pocket lacks even a shallow depression, as it is filled
by bulky, aromatic side chains (F1397, Y1406,
W1408, and F1434). Thus, in contrast to nSH2 and
consistent with the lack of sequence conservation at
cSH2 (Fig. 6c), it seems unlikely that cSH2 binds
ligands in a manner reminiscent of SH2 domains.
Binding of Spt6 tSH2 domain with
phosphorylated peptides
The human Spt6 CTD has been reported to bind
the heptad repeat sequences of the mammalian
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RNAPII large subunit when the RNAPII CTD is
treated with P-TEFb, a kinase that phosphorylates
Ser2 during transcriptional elongation.9 In order to
investigate this interaction more quantitatively, we
used fluorescence anisotropy (FA) to measure
binding of S. cerevisiae Spt6(1247–1451) to di-heptad
repeat peptides representing various phosphoiso-
forms of the RNAPII CTD (Fig. 8). Peptides tested
include sequences representing phosphoserine
(pSer) 2, pSer5, pTyr1, and pSer(2,5). pSer5 and
pSer(2,5) peptides were included to test specificity
and because these modifications also occur on the
RNAPII heptad repeats. A pTyr1 peptide was
included because SH2 domains typically bind pTyr
peptides and this modification occurs in
mammals,40 although it has not been reported to
occur in yeast.
All of the peptides assayed bound with affinities in
the range of ∼20–250 μM, which is similar to the
affinity of other RNAPII CTD interactions with
isolated binding domains,41 but is ∼10- to 100-fold
weaker than is typically found for the interaction of
SH2 domains with pTyr ligands.42 Of the ligands we
assayed, the pSer(2,5) peptide bound Spt6(1247–1451)
with the highest affinity (23 μM). This may indicate
that RNAPII CTD sequences phosphorylated on
both Ser2 and Ser5 are the authentic in vivo ligands
for the yeast Spt6 tSH2 domain, which would be
consistent with the reports that Ser2-phosphorylated
sequences are preferred9 and that localization of
Ser2 and Ser2/5 phosphorylation overlaps substan-
tially in average transcription units.43,44 On the
other hand, interpretation is complicated by the fact
that our pSer2/5 peptide has considerably more
negative charge than the other peptides assayed and
thus may be more prone to nonspecific effects.
Interestingly, the pTyr1 peptide binds with a Kd of
110 μM, which is tighter than that of the pSer2
(197 μM) and pSer5 (245 μM) peptides bearing an
equivalent number of phosphate groups. A higher
affinity for pTyr1 peptide with the same overall
charge as pSer2 or pSer5 peptide is consistent with
the similarity between nSH2 and well-characterized
pTyr binding SH2 domains, but the physiological
relevance of this result is not clear given the lack of
observed pTyr modification of the RNAPII CTD in
yeast.
The conclusion that the Spt6 tSH2 domain inter-
acts specifically with phospho-CTD peptides is
reinforced by our observations that an unpho-
sphorylated form of the RNAPII CTD showed
negligible (Kd of N1000 μM) binding and that similar
results were obtained when the assays were
performed under a phosphate-buffered saline con-
dition (data not shown). As a further test of specific
interactions, we measured binding to a mutant form
of Spt6(1247–1451) in which residues R1282 and
S1284, which are important for phosphate binding
in typical SH2 domains, were both substituted with
alanine. Binding to the pSer(2,5) peptide was
decreased by ∼4-fold, while binding to the pTyr1,
pSer2, and pSer5 peptides was decreased by 2.4-
fold, 1.2-fold, and 1.4-fold, respectively. These
modest effects are consistent with the putative
nSH2 phosphate binding site contributing to the
binding interaction but not performing a dominant
role for interaction with the peptides assayed.
Deletion of the entire tSH2 region by truncation of
the SPT6 gene leads to defects in growth attributed
Fig. 8. Spt6 tSH2 binds RNAPII CTD phosphopeptides.
(a) Peptides used in binding studies with positions of pSer
and pTyr residues indicated. (b) Representative FA
binding isotherms for Spt6(1247–1451) binding to various
peptides with symbols defined in (c). (c) Binding affinities
for WT and R1282A/S1284A Spt6(1247–1451) proteins
based on FA experiments.
707Crystal Structures of SPT6
52
to suboptimal transcription elongation.22,23 To exam-
ine the importance of tSH2 residues implicated in
pTyr binding in vivo more carefully, we mutated the
single genomic copy of SPT6 to produce proteinswith
R1282H, S1284D, R1286A, Q1303E, EN1313/
1314AA, or K1343E mutation (nSH2 domain) or
P1390A or K1411E mutation (cSH2 domain). The
effects of these mutations were quite mild, failing to
recapitulate the severe defects caused by truncation of
the gene (data not shown; see Materials andMethods
for a list of phenotypes screened). The C-terminal
region of Spt6 therefore appears to have some activity
that is not interrupted when residues within the tSH2
domain expected to be important for binding
phosphorylated substrates are mutated.
Our data are consistent with a recent report that
concluded that pSer2 RNAPII CTD peptides bound
the tSH2 domain of the C. glabrata Spt6 homolog
with an affinity of 10 μM.22 The tighter affinity
observed in that study could reflect differences
between the proteins but is more likely to be due to
the very low (10 mM) concentration of NaCl used in
the binding assays. Our data also extend the earlier
work by showing that the S. cerevisiae Spt6 tSH2
domain displays little discrimination for binding
CTD peptides with different modifications but does
show a small preference for a peptide with a single
phosphorylated tyrosine (pTyr1). Our findings
suggest that Spt6 activities in vivo may be modulat-
ed by phosphorylation of binding partners and that
the ligands of the tSH2 domain may include
phosphorylated tyrosine residues.
Binding to dsDNA
To test whether Spt6 is capable of binding dsDNA,
we performed electrophoretic mobility gel shift
assays using a 177-bp dsDNA fragment. We tested
several different Spt6 constructs and found that
binding was tighter (Kd±standard deviation) for
Spt6(315–1451) (Kd of 0.53±0.07 μM) than for Spt6
(239–1451) (Kd of 33.7±3.8 μM) or Spt6(1–1451) (Kd
of 106.7±38.9 μM) (Fig. 9), demonstrating that the
disordered and negatively charged N-terminal
residues diminish dsDNA binding. Unlike Tex,
which requires the S1 domain for nucleic acid
binding,21 an Spt6 construct lacking the S1 domain,
Spt6(315–1117), retains the ability to bind dsDNA
with a Kd of 1.08±0.06 μM (Fig. 9b).
Overall structure and functional implications
Our composite model of Spt6 (Fig. 10) features a
core region (residues ∼298–1117) that has multiple
recognizable domains whose packing in the crystal
likely reflects, to a large extent, their organization in
solution, at least in the absence of binding partners.
The N-terminal residues 1–297 display considerable
overall negative charge and are expected to be
highly mobile, while residues 239–263 also comprise
the Spn1/Iws1-binding determinant and overlap
with the nucleosome binding site.14 This high
degree of mobility may provide a flexible tether
for bridging binding partners, such as Spn1/IwsI,
RNAPII, and nucleosomes,9 and the negative charge
may modulate histone and DNA interactions.
Inherent flexibility is also a feature of the C-terminal
S1 domain, H44, and tSH2 domain. The S1 domain is
loosely associated with the core, lacks density in the
Spt6(236–1259) structure, and may be visible in the
Spt6(239–1451) structure only because of ordering by
a crystal lattice contact. Whereas the core of the
distantly related Tex protein clearly resembles that
of Spt6, the Tex and Spt6 S1 domains are displaced
Fig. 9. dsDNA binding studies. (a) Representative gel
shift assays for three different constructs of Spt6. (b)
Representative binding isotherms used to calculate disso-
ciation constants for various Spt6 constructs binding to the
177-bp Widom 601 dsDNA.45 Symbols used to indicate
isotherms for different constructs are as follows: (+) Spt6
(1–1451), Kd = 106.7 ± 38.9 μM; (Δ) Spt6(239–1451),
Kd=33.7±3.8 μM; (×) Spt6(315–1117), Kd=1.08±0.06 μM;
(○) Spt6(315–1451), Kd=0.53±0.07 μM. (c) Schematic
diagram indicating endpoints for constructs used in
DNA binding studies.
708 Crystal Structures of SPT6
53
by a rotation of ∼80° and ∼25- to 30-Å translation
with respect to each other, and the S1 domain
appears to be shifted by 14 Å in different crystal
forms of Tex.21 Therefore, it is likely that a highly
mobile S1 domain is an important feature of both
proteins, although one notable difference is that the
Tex S1 binds nucleic acids, whereas our DNA
binding data and consideration of surface amino
acid residues indicate that the Spt6 S1 domain does
not. Although the low conservation of residues in
the putative binding cleft of the S1 domain suggests
that this region is unlikely to have a highly
conserved binding partner, the electrostatic charac-
teristics of this surface (Fig. 5) are consistent with
potential binding partners that are positively
charged, such as histones.
H44 is visible only in the Spt6(236–1259) structure,
where it also appears to be ordered by a lattice
contact, and the C-terminal tSH2 domain is expected
to be highly dynamic with respect to the rest of the
protein. The leading model is that this domain binds
RNAPII that is phosphorylated on Ser2 of its CTD.9
Our binding data are consistent with this view,
provided that other determinants contribute to
binding/specificity, but also indicate the possibility
that other binding partners might be functionally
important. For example, Spt5 (discussed below) has
been shown to co-localize with Spt6 and contains a
phosphorylated C-terminal repeat domain similar to
the RNAPII CTD,46 which could be a physiological
ligand for the Spt6 tSH2 domain.
Spt6 has been shown to be functionally associated
with a large number of proteins involved in
transcription elongation, chromatin maintenance,
and RNA processing. The structure of Spt6 pre-
sented here will serve as a foundation for a more
precise mapping of protein binding partners. Along
with protein binding partners, Spt6 is also expected
Fig. 10. Comparison of Spt6 and Tex structures. The overall structure of the Spt6 core resembles that of the prokaryotic
Tex protein. This similarity implicates the Spt6 core in nucleosome-independent functions, such as transcriptional
elongation on naked template DNA. The N-terminal region includes determinants essential for binding Spn1/Iws1 or
nucleosomes, which appear to bind competitively with each other.14 The negatively charged N-terminal region may also
be important for modulating binding to nucleic acids. The C-terminal region has been implicated in binding RNAPII.9
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to interact with nucleic acids in the transcription
complex. DNA binding is probably important for
nucleosome reassembly and potentially for tran-
scription elongation. Association with nascent RNA
transcripts could be important for enhancing the
elongation rate or for organizing interactions with
RNA modification/export factors such as REF/Aly.
Future studies will be needed to see if Spt6 binds
RNA and to further map nucleic acid binding to
different domains of Spt6. For example, the YqgF or
the (HhH)2 domain may mediate binding to specific
DNA structures such as four-way (Holliday) junc-
tion DNA, structures similar to those found at the
DNA entry/exit points of nucleosomes.47 The tSH2
domain may also contribute to nucleic acid interac-
tions, as it is likely to bind negatively charged
substrates containing phosphate groups. A simple
electrostatic surface analysis indicates that each of
these domains retains properties found in homolo-
gous domains with known functions. Furthermore,
examination of the histone-binding activity of the
various Spt6 domains will be of significant interest
in furthering our understanding of nucleosome
assembly/reassembly.
The structural similarity between Spt6 and the
prokaryotic Tex protein is limited to the core and S1
domains. Consistent with the extent of structural
similarity, N- and C-terminal regions that are
unique to Spt6 are required for eukaryotic-specific
interactions with nucleosomes,11,13,14 hyperpho-
sphorylated forms of the RNAPII CTD,9 Spn1/
IwsI,14 and mRNA processing/export factors.9 An
attractive possibility is that the core region provides
activities that are conserved among prokaryotes and
eukaryotes. In this regard, it is striking that most of
the Spt6 core domains belong to structural families
whose members function in nucleic acid binding, an
activity that is likely to be a key component of
transcription factors such as Spt6 and Tex that are
capable of stimulating elongation on nucleosome-
free DNA templates.9,16 Consistent with this possi-
bility, our data indicate that the Spt6 core can bind
dsDNA. Curiously, some of the putative nucleic-
acid-binding surfaces of Spt6 domains are occluded
in the structure, although conformational changes
might displace residues 298–320 (H1 and H2) to
expose a DNA-binding activity on the (HhH)2
domain. Consistent with this model, we find that
truncation of ∼314 N-terminal residues leads to
tighter dsDNA binding. One attractive model is that
conformational changes of this nature are induced
by binding partners such as histones or Spn1/Iws1.
The relationship between Spt6 and Tex proposed
here is reminiscent of that between another eukary-
otic transcription elongation factor, Spt5, and its
bacterial counterpart, NusG. These proteins also
display similar core domains, while Spt5 has an
acidic N-terminal extension and a C-terminal
extension48 that confers eukaryote-specific functions
such as binding to RNAPII,48 interaction withmRNA
capping enzymes,49 and extensive phosphorylation
by RNAPII CTD kinases such as P-TEFb.50 Therefore,
like Spt5, Spt6 is likely to have built on the
fundamental transcription activities of its core to
accommodate the additional complexities of eukary-
otic gene regulation.
Materials and Methods
Protein expression and purification
The protein constructs were expressed from pET151-D/
TOPO vectors (Invitrogen) in BL21 codon plus (RIL) E. coli
cells (Stratagene). Cultures were grown in autoinduction
media51 in baffled 1.8-l flasks at 37 °C with continuous
shaking. After 4–8 h, the cultures were shifted to 23 °C and
grown for an additional 16–24 h. Harvested cells were
stored at −80 °C. Cells were thawed and lysed in buffer
containing lysozyme and protease inhibitors, followed by
sonication and centrifugation (25,000–30,000g). The solu-
ble fraction was applied to nickel agarose resin (Qiagen)
and eluted in buffer containing 300 mM imidazole and
100 mM NaCl, immediately followed by application to a
heparin column (5-ml HiTrap Heparin; GEHealthcare Life
Sciences) and elution over a NaCl gradient. Fractions
containing Spt6 were pooled and processed overnight at
room temperature in buffer containing tobacco etch virus
protease. A nickel agarose columnwas used to remove the
tagged tobacco etch virus protease and unprocessed Spt6
protein, and the flow-through was concentrated and
loaded onto a size-exclusion column [Superdex 200 or
S75 (for 1247–1451 constructs); GE Healthcare Life
Sciences]. SeMet protein was expressed using an auto-
induction protocol51 for selenomethionine incorporation
and purified by the same protocol as native protein. All
crystals were grown in sitting drops, transferred briefly to
a cryoprotection solution, suspended in a nylon loop, and
plunged into liquid nitrogen (Table 1).
Crystal structure determinations and refinements
Data were processed with HKL2000.52 Spt6(236–1259)
was determined by the multiple-wavelength anomalous
diffraction method. SOLVE53 was used to locate selenium
atoms, and RESOLVE54 was used for density modification
and preliminarymodel building. AutoSol in PHENIX26 was
used to determine the Spt6(1247–1451) structure by the
single-wavelength anomalous diffraction method. The Spt6
(239–1451) structure was determined by molecular replace-
ment usingAutoMR in PHENIX26 to a resolution of 3.3Å.A
homology model built by TASSER55 of the Spt6 S1 domain
was used as a guide for model building. The native Spt6
(1247–1451) structure was determined by molecular re-
placement using Phaser.56 PHENIX26 and TLSMD57 were
used for refinement, Coot58 was used for model building,
and MolProbity27 was used for structure validation. The
following residueswere ordered and included in the refined
models: Spt6(236–1259) 297–455, 464–484, 501–561, 567–
1002, 1009–1128, and 1219–1248; Spt6(239–1451) 312–455,
464–489, 509–552, 567–649, 653–1001, and 1014–1210; and
710 Crystal Structures of SPT6
55
Spt6(1247–1451) 1247–1440. Structural alignments were
performed using Dali59 and SSM.60 PyMOL61 was used to
create the figures. Electrostatic surface representations were
calculated using PDB2PQR and APBS tools62,63 using the
AMBER force field and colored from red (−5 kT/e) to blue
(+5 kT/e).
DNA binding experiments
Widom601DNA (177 bp)with a 5′Cy3 fluorophorewas
generated as described45 followed by precipitation, gel
purification, and electroelution. Electrophoretic mobility
shift binding experiments were performed, and Kd values
were determined as described previously.21 In short, 2-fold
serial dilutions of the respective purified protein construct
were mixed with nucleic acid substrate at room temper-
ature in binding buffer [15 mMTris–HCl (pH 7.5), 100 mM
NaCl, 10% glycerol, and 0.5 mM ethylenediaminetetraa-
cetic acid] where the final concentration of dsDNA was
10- to 20-fold below the estimated Kd for the interaction.
After incubation for 30 min, samples were run on 4–20%
TBE native gels (Bio-Rad Laboratories) and imaged and
quantified using a TYPHOON imaging system with
ImageQuant software (GE Healthcare Life Sciences). The
fraction boundwas calculated by quantifying the DNAtotal
(total fluorescence in entire lane) and DNAfree. DNA of
slower mobility than the DNAfree was considered bound.
The fraction bound=1− ([DNA]free/[DNA]total). Dissocia-
tion constants (Kd values) were calculated by plotting data
points and curve fitting in the program R64 using the Hill
formalism where fraction bound=1/(1+(Kdn/[P]n)). In
all cases, standard deviations are calculated from at least
three measurements, except for the Spt6(315–1117) con-
struct, which was repeated twice.
FA binding experiments
Peptides were synthesized by the University of Utah
Core Facility or purchased commercially through AnaSpec
Inc. (San Jose, CA), purified to N98% purity by HPLC, and
confirmed by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry. Purified Spt6(1247–1451)
was titrated in 1.5- to 2.0-fold serial dilutions against a
constant concentration of fluorescein-labeled peptide
(10- to 20-fold below estimated Kd) in 20 mM Tris–Cl
(pH 7.5), 100 mM NaCl, and 5% glycerol. Samples were
incubated at room temperature for at least 15 min prior to
reading. Parallel and perpendicular fluorescence intensity
was measured in a multi-well format using a Tecan Infinite
200 microplate reader using excitation/emission wave-
lengths of 485 nm/535 nm. Anisotropy values were
calculated, normalized, and plotted as a function of
protein concentration. Kd values were determined by
fitting the data using the equation65 A=((AT× ([pro]/
Kd))/(1+[pro]/Kd)), where A is the measured anisotropy,
AT is the total change in anisotropy, and [pro] is the
protein concentration.
Genetic analysis of tSH2 mutations
The following alleles of SPT6 were screened for
phenotypes in strains isogenic with the A364a genetic
background: wild type (WT), spt6-R1282H, spt6-S1284D,
spt6-R1286A, spt6-Q1303E, spt6-E1313A, N1314A, spt6-
K1343E, spt6-P1390A, and spt6-K1411E. Mutations were
introduced into the genomic copy of SPT6 such that
expression was from the native promoter at the normal
locus except for the introduction of a URA3 or TRP1
marker downstream of the open reading frame. Strains
were tested for growth on rich medium at 30 °C and 38 °C;
on medium lacking lysine at 30 °C and 37 °C (all strains
had the lys2-128∂ allele; thus, growthwould reveal an Spt−
phenotype); and on media containing 150 mM hydroxy-
urea, 75 μg/ml 6-azauracil, 0.6 μg/ml 4-nitroquinolone,
10 mM caffeine, 3% formamide, 1.2 M NaCl, 45 μg/ml
mycophenolic acid, or 6% ethanol (all at 30 °C). None of
the mutants were sensitive to any of the stress conditions
relative to the WT strain. spt6-S1284D and spt6-Q1303E
strains were somewhat more resistant to 3% formamide
than the WT, and spt6-Q1303E strains displayed a very
weak Spt− phenotype (faint growth after 7 days). Mutants
were not tested for a defect in cryptic initiation.
PDB accession numbers
Coordinates and structure factors for Spt6(236–1259),
Spt6(239–1451), and SeMet Spt6(1247–1451) and native
Spt6(1247–1451) have been deposited in the PDB with
accession numbers 3psf, 3psi, 3psj, and 3psk, respectively.
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Supplemental Figure Legend 
 
Figure S1.  Spt6 Conservation. 
Spt6 protein from various eukaryotic species were aligned using T-Coffee1 and ESPript2 
was used for visualization.  Coloring of sequence represents degree of conservation, dark 
red background (invariant), orange font (conserved), in an alignment of proteins from 
Saccharomyces cerevisiae (S.c.), Schizosaccharomyces pombe (S.p.), Caenorhabditis 
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SUMMARY
Eukaryotic transcription and mRNA processing
depend upon the coordinated interactions of many
proteins, including Spn1 and Spt6, which are
conserved across eukaryotes, are essential for
viability, and associate with each other in some of
their biologically important contexts. Here we report
crystal structures of the Spn1 core alone and in
complex with the binding determinant of Spt6.
Mutating interface residues greatly diminishes
binding in vitro and causes strong phenotypes
in vivo, including a defect in maintaining repressive
chromatin. Overexpression of Spn1 partially
suppresses the defects caused by an spt6 mutation
affecting the Spn1 interface, indicating that the
Spn1-Spt6 interaction is important for managing
chromatin. Spt6 binds nucleosomes directly
in vitro, and this interaction is blocked by Spn1,
providing further mechanistic insight into the func-
tion of the interaction. These data thereby reveal
the structural and biochemical bases of molecular
interactions that function in the maintenance of chro-
matin structure.
INTRODUCTION
Spn1 and Spt6 are transcription factors that interact with one
another and are each essential for viability in yeast (Clark-Adams
andWinston, 1987; Fischbeck et al., 2002). S. cerevisiae Spn1 is
a 410 residue, 46 kDa protein with a central core domain (resi-
dues 140–300) that is flanked on both sides by regions that are
predicted to be disordered (Ward et al., 2004). Spt6 is a 1451
residue, 168 kDa protein whose core (residues 300–1250) likely
resembles the structure of the bacterial Tex protein (Johnson
et al., 2008) with an acidic N-terminal extension that is expected
to be unstructured (Ward et al., 2004) and a C-terminal domain
(CTD) that adopts an SH2 fold (Dengl et al., 2009; Maclennan
and Shaw, 1993). Spn1 and Spt6 interact stably with one
another, and they and their interaction have been implicated in
several aspects of gene expression (Krogan et al., 2002; Lind-
strom et al., 2003; Yoh et al., 2007; Yoh et al., 2008).
Spt6 was originally identified in a screen for factors that alter
normal initiation of transcription (Clark-Adams and Winston,
1987; Denis, 1984; Neigeborn et al., 1987; Simchen et al.,
1984). Subsequently, Spt6 was implicated in a variety of biolog-
ical processes in organisms ranging from yeasts to humans,
including embryogenesis in Zebrafish (Keegan et al., 2002; Kok
et al., 2007), multiple stages of development in Drosophila
(Ardehali et al., 2009), gut morphogenesis in C. elegans (Nishi-
waki et al., 1993), signal transduction in mammals (Baniahmad
et al., 1995; Shen et al., 2009), and HIV transcription regulation
and mRNA processing in human cells (Vanti et al., 2009; Yoh
et al., 2007). The role in transcription initiation has been ascribed
to the ability of Spt6 to chaperone histones to promote reassem-
bly of nucleosomes in the wake of RNA polymerase II (RNAPII),
thereby reestablishing the default repressive chromatin state
that prevents inappropriate initiation of transcription (Adkins
and Tyler, 2006; Bortvin and Winston, 1996; Cheung et al.,
2008; Kaplan et al., 2003). While of profound importance, main-
taining repressive chromatin appears to be just one of Spt6’s
roles. For example, Spt6 also promotes elongation by RNAPII
(Hartzog et al., 1998; Kaplan et al., 2005; Kaplan et al., 2000;
Lindstrom et al., 2003) on nucleosome-free DNA templates
in vitro (Endoh et al., 2004; Hartzog et al., 1998; Keegan et al.,
2002; Yoh et al., 2007), as well as on chromatin templates
in vivo (Ardehali et al., 2009). Together, these data indicate that
Spt6 plays a number of mechanistically distinct roles during
transcription.
The SPN1 gene was originally identified as a key regulator of
transcription from genes that are regulated postrecruitment of
RNAPII (Fischbeck et al., 2002). Spn1 was also identified as
a protein that interacts with Spt6 and has been reported to
bind with Spt6 in some but not all of Spt6’s functional states
(Lindstrom et al., 2003; Yoh et al., 2007; Zhang et al., 2008).
For example, Spt6 can be coimmunopurified with three distinct
Spt4/5-RNAPII complexes, whereas Spn1 is found in only two
of these complexes (Lindstrom et al., 2003). The CYC1 gene of
S. cerevisiae provides an example of how the Spn1-Spt6 interac-
tion contributes to postrecruitment regulation (Zhang et al.,
2008). RNAPII is constitutively bound to the CYC1 promoter,
but is kept from elongating because it interacts with Spn1,
which in turn inhibits the Swi/Snf nucleosome remodeling
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complex from promoting transcription. During activation,
Spt6 binds to Spn1, and repression of Swi/Snf recruitment is
relieved.
Spn1 is also needed to achieve normal recruitment of the
histone methyltransferase HYPB/Setd2 (Yoh et al., 2008) and
the elongation factor TFIIS (Ling et al., 2006; Zhang et al.,
2008) to RNAPII complexes traversing active genes. HYPB/
Setd2 methylates histone H3K36, which in turn recruits Rpd3-
type histone deacetylases to restore chromatin to the repressive
hypoacetylated state and block inappropriate transcription
(Yoh et al., 2008). In contrast to their antagonistic relationship
in activating postrecruitment initiation, Spn1 and Spt6 each
contribute toward restoration of repressive chromatin. Human
Spn1/IWS1 also binds the protein arginine methyltransferase
PRMT5, which methylates the elongation factor Spt5 and
thereby regulates its interaction with RNAPII (Liu et al., 2007).
Spn1 can additionally function through interactions with
pathway-specific regulatory factors, such as the Arabidopsis
steroid hormone responsive transcription factor BES1, which
recruits Spn1 to the promoter and transcribed regions of acti-
vated genes (Li et al., 2010). Spn1 therefore contributes in
several ways to the appropriate functioning of RNAPII.
In addition to their roles in regulating transcription, Spt6 and
Spn1 also collaborate to promote mRNA processing and export.
Spt6 is required for proper 30 end formation by preventing
premature 30 processing at upstream polyadenylation signals
(Bucheli and Buratowski, 2005; Kaplan et al., 2005). Further,
mammalian Spt6 can bind the Ser2-phosphorylated RNAPII
CTD, enhancing recruitment of RNA processing/export factors
(Yoh et al., 2007, 2008), and Drosophila Spt6 copurifies with
the RNA processing exosome complex (Andrulis et al., 2002).
Both SPN1 and SPT6 have also been implicated in mRNA
splicing in S. cerevisiae (Burckin et al., 2005), and binding of
human Spn1/IWS1 to the RNA export factor REF1/Aly is impor-
tant for recruitment of REF1/Aly to the body of the c-Myc gene
during transcription (Yoh et al., 2007).
Spt6 and Spn1 and their interaction with one another therefore
play pivotal roles in defining the composition of RNAPII elonga-
tion complexes, maintaining the structure of chromatin, and
modulating the production of mature mRNA transcripts. To
advance mechanistic understanding of their functions, we have
determined the structural basis of the Spn1-Spt6 interaction.
We also demonstrate the importance of this interface in vitro
and in vivo, and show that Spn1 negatively regulates binding
of Spt6 to nucleosomes.
RESULTS
Mapping of the Spn1-Spt6 Interface
Full-length S. cerevisiae Spt6 and Spn1 proteins were poorly
behaved, but deletion of much of their presumably unstructured
N-terminal regions (Ward et al., 2004) allowed us to observe
coelution of a complex of recombinant Spn1(120–410) and
Spt6(206–1451) by size-exclusion chromatography in sodium
chloride concentrations up to 300 mM (data not shown). Spt6
(239–1451) also bound Spn1, whereas Spt6(315–1451) did not.
Further truncations revealed that Spt6(239–268) is sufficient for
Spn1 binding (Figures 1A and 1B). This 30 residue segment of
Spt6 is predicted to be unstructured, and comes from a region
that is N-terminal to the region expected to resemble the struc-
ture of the bacterial protein Tex (Johnson et al., 2008). Spn1
(148–293) includes most of the Spn1 residues that are predicted
to be structured and retained the ability to bind Spt6. The slightly
larger Spn1(141–305) fragment was previously shown to
complement a deletion of SPN1 (Fischbeck et al., 2002), indi-
cating that this core domain provides the major function(s) of
Spn1 in vivo. Isothermal titration calorimetry (ITC) was used to
measure binding affinities of Spn1(148–293) for two different
Spt6 constructs: Spt6(239–1117), the largest Spt6 construct
that remained soluble at sufficient concentrations for these
experiments, and Spt6(239–268), the smallest construct tried
that retained full binding affinity. In both cases the binding dis-
played 1:1 stoichiometry and the mean binding constant (KD)
was 170 nM (Figures 1C and 1D and see Table S1 available on-
line). This indicates that the 30 residue segment of Spt6, Spt6
(239–268), is sufficient to recapitulate the binding energy
observed for larger Spt6 constructs.
Crystal Structures of the Spn1 Core
The crystal structure of Spn1(148–307) was determined by the
single-wavelength anomalous diffraction method using data
collected to 3.0 A˚ resolution from a selenomethionine-
substituted crystal (Figure 2A, Table 1). This unrefined model
was used in molecular replacement calculations with 2.15 A˚
data from a native crystal that belonged to a different space
group, and the native structure was refined to Rwork/Rfree values
of 18.5%/22.4%. Residues 148–295 were clearly observed in
the electron density, as were four nonnative N-terminal residues
that remained after TEV digestion. The 12 C-terminal residues
were disordered and are not included in the final model.
Spn1(148–307) forms a right-handed superhelical bundle of
eight helices (named H1–8, Figure 2A). Surprisingly, this struc-
ture resembles the domains of the RNA processing factors
Pcf11 (S. cerevisiae) (Meinhart and Cramer, 2004) and SCAF8
(human) (Becker et al., 2008) that bind the RNAPII CTD
(Figure S1A). Spn1 is reported to associate with RNAPII (Zhang
et al., 2008), and the structural similarity suggested that Spn1
might bind the RNAPII CTD. We have not, however, observed
binding in a fluorescence polarization assay between the Spn1
core and synthetic peptides, either phosphorylated or unphos-
phoryalated, that span more than two heptad repeats of the
RNAPII CTD (data not shown).
Crystal Structure of an Spn1-Spt6 Complex
The structure of an Spn1(148–293):Spt6(239–268) complex was
determined by molecular replacement and refined to Rwork/Rfree
values of 18.6%/24.4% against 2.15 A˚ resolution data (Fig-
ure 2B, Figure S2, Table 1). There are two complexes in the
asymmetric unit that superimpose closely with an rmsd of
!0.5 A˚ over all 170 native ordered Ca atoms. Residues 148–
292 of Spn1 are clearly visible in the electron density, as are
six nonnative N-terminal residues that remain after TEV diges-
tion. Residues 239–263 of Spt6 are also clearly defined in the
electron density as well as four nonnative N-terminal residues.
There is no clear electron density for the five C-terminal residues
of Spt6 and the one C-terminal residue of Spn1, and these are
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not included in the final model. Spn1 retains the same globular
eight helix-bundle fold in the complex, showing no notable
conformational changes upon binding Spt6 (rmsd !0.5 A˚ on
135/145 pairs of Ca atoms). Binding of Spt6 to Spn1 does not
mimic the binding of RNAPII CTD peptides to Pcf11/SCAF8, as
it involves a face of Spn1 that is structurally distinct from the
binding surface of Pcf11/SCAF8 (Figure S1B).
The structure of the Spn1(148–293):Spt6(239–268) complex
reveals an extensive interface in which the Spt6 residues drape
across the structured Spn1 core domain as two helices, H1 (resi-
dues 239–249) and H2 (256–265), that are connected by a short
extended segment. There are multiple contacts along the length
of the Spt6 segment that bury a total of 1790 A˚2 of accessible
surface area upon complex formation. Spt6 H1 and the connect-
ing segment, in particular, include a high fraction of conserved
residues and contact a conserved patch on the Spn1 surface,
thereby indicating that this interface is likely to be preserved
across eukaryotes (Figures 2C–2E, Figures S1C and S1D).
Distinctive hydrophobic and polar interactions are made
throughout the length of the Spt6 peptide (Figure 3). Starting at
Figure 1. The Spn1 Core Binds 30 Residues
in the Spt6 N-Terminal Region
(A) Spt6 and Spn1 domain organization and their
interacting regions. Constructs assayed for
binding are indicated above (Spt6) or below
(Spn1) with their N- and C-terminal residues given.
Constructs that showed binding are colored black,
while those that did not show binding are colored
red.
(B) Overlays of size-exclusion chromatograms
with Spn1 in black, Spt6 in orange, and binding
experiments in blue. Chromatograms are scaled
on the y axis to allow comparison of the elution
volume profiles of each protein or binding experi-
ment. Spn1 has a 6-fold lower molar extinction
coefficient, and so at equimolar concentrations,
the Spn1 peak appears approximately six times
smaller than the Spt6 peak (blue, middle panel).
The x axis shows the 50–100 ml elution volume.
(C) Raw ITC data of the titration of Spn1(148–293)
into Spt6(239–1117) (top) and the titration of Spt6
(239–268) into Spn1(148–293) (bottom).
(D) Representative binding isotherms of the titra-
tion experiments from (C). See text and Table S1
for thermodynamic parameters.
the Spt6 peptide N terminus, the H1 resi-
dues M245, I248, and F249 contact
a hydrophobic pocket formed by Spn1
residues L256, G262, I266, I286, and
W289. The C-terminal carbonyl groups
of Spt6 H1 form water-mediated
hydrogen bonds with Spn1 R263 guanidi-
nium, whose extensive network of
contacts also includes direct hydrogen
bonds with the carboxylate of D254 in
the extended region of Spt6. The
aromatic side chain of Spt6 Y255, from
the extended central region, makes van
der Waals contacts with Spn1 P227, V264, and F267, while its
hydroxyl group forms a hydrogen bond with the carboxylate of
Spn1 E226. The Spt6 H2 residues W257, A258, L259, and I261
contact two hydrophobic patches formed by Spn1 P227,
G231, V264, and F267. Finally, the Spt6 E262 carboxylate
hydrogen bonds with Spn1 S271 and R273, and K272 forms
polar contacts with the amide of Spt6 N263. These extensive
interactions are consistent with the strong specific binding
observed between Spn1 and Spt6.
Mutations that Disrupt Spn1-Spt6 Complex Formation
In Vitro
To validate the relevance of the interface seen in the crystal
structure, Spn1(148–293) and Spt6(239–268) variants were ex-
pressed and purified, and binding affinities were measured by
ITC (Figure 4, Figure S3, Table S1). The Spt6-F249K protein
bound Spn1 with a mean KD of 11 mM, a reduction in affinity
compared to the WT interaction of about 60-fold. The affinity of
the Spn1-R263D protein for Spt6 (mean KD of 30 mM) was
reduced about 170-fold compared to WT. No binding was
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detected for the Spn1-F267E protein at concentrations expected
to give a reliable estimate of affinity around 40 mM. These obser-
vations validate the crystallographic interface and demonstrate
that single point mutations are sufficient to significantly reduce
binding affinity in vitro.
Mutating the Spn1-Spt6 Interface Causes Profound
Effects In Vivo
To determine the physiological importance of the Spn1-Spt6
interaction, we introduced spt6-F249K, spn1-R263D, and
spn1-F267E mutations into the genomes of yeast cells such
that eachmutant protein was expressed from its native promoter
as the sole source of the affected protein. spt6-F249K caused
a moderate growth defect at low temperatures, and this was
strongly enhanced at elevated temperatures (Figure 5A). Strains
with the spn1-R263D mutation grew normally at all tempera-
tures, while those with the spn1-F267E mutation were normal
at low temperatures but failed to grow at high temperatures.
Each of the three mutations caused a defect in transcription initi-
ation site selection due to defective chromatin repression, as
indicated by the Spt! phenotype (growth of a strain with the
lys2-128v allele on medium lacking lysine (Simchen et al.,
1984; Figures 5A–5C). The strength of the defect was different
for each mutation, being weakest for spt6-F249K, stronger for
spn1-R263D, and strongest for spn1-F267E. This order corre-
lates precisely with the level of perturbation of binding observed
with these mutant proteins in vitro (Figure 4, Table S1), strongly
supporting the importance of the Spn1-Spt6 binding interface
detected in our crystal structure inmaintaining a repressive chro-
matin state in vivo.
Eachmutation in theSpn1-Spt6binding interfacedisturbed the
interaction to a different extent in vitro (Figure 4, Table S1), but
each individual mutation was tolerated in vivo (Figure 5). If the
phenotypes caused by individual mutations result from partial
disruption of binding, then combining the mutations should
lead to enhanced defects. Consistent with this prediction, cells
with both spt6-F249K and spn1-R263D mutations were viable
but severely impaired for growth (Figure 5A), and cells with both
spt6-F249K and spn1-F267E were inviable (Figure S4D). The
severity of the defect caused by combining mutations therefore
correlates with the level of disruption of binding by the individual
mutations, suggesting that the Spn1-Spt6 interaction is essential
for viability. We were unable to detect an interaction between
Spt6 and Spn1-F267E in vitro (Figure 4), but the viability of the
spn1-F267E strain suggests that this mutant retains some
binding.Combining spt6-F249Kwith spn1-K192Nwasalso lethal
(Figure S4D); thismutation does not directly affect the Spn1-Spt6
interface (Figures2Band2C) but hasbeenshown todecrease the
Figure 2. Structures of the Spn1 Core and
Its Complex with Spt6
(A) The structure of the Spn1 core shown as
a cartoon representation in two orthogonal views.
The polypeptide chain is colored as a blue to red
rainbow from N to C terminus. Secondary struc-
tures and the N and C termini are labeled.
(B) Structure of the Spn1-Spt6 complex. The Spn1
core is shown as a surface electrostatic (±5 kT/e)
representation in the same views as (A). Spt6 is
colored yellow and the N and C termini and the
helices are labeled. Spn1 K192 has been impli-
cated in interactions with RNAPII (Zhang et al.,
2008) and lies in the basic conserved pocket indi-
cated. Remnants of the affinity tags that remain in
the crystallized Spn1 and Spt6 proteins are not
shown in any of the figures and do not contribute
to the Spn1 interface.
(C) Same as (B), except that the Spn1 surface and
Spt6 peptide are colored according to conserva-
tion.
(D) Spn1 core amino acid sequence. Secondary
structural elements are indicated above, and
were defined with ESPript (Gouet et al., 2003).
Residues that make direct contact across the
interface are indicated with a black square or
with an asterisk if they were mutated in this study.
Numbering and residue identities shown here
refer to the S. cerevisiae protein. Coloring repre-
sents degrees of conservation, dark green (high),
light green (medium), in an alignment of proteins
from Saccharomyces cerevisiae, Schizosaccharo-
myces pombe, Caenorhabditis elegans,
Drosophila melanogaster, Danio rerio, and Homo
sapiens. Amino acid sequences were aligned using the T-coffee multiple sequence alignment method (Notredame et al., 2000) and slightly adjusted manually
in light of the structure (Figure S2).
(E) Same as (D) but for Spt6. High conservation (red), medium conservation (yellow).
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interaction between Spn1 and RNAPII (Zhang et al., 2008), and
our results with the recombinantly expressed protein suggest
that Spn1-K192N protein is unstable (data not shown). Synthetic
growth defects therefore support the importance of the Spn1-
Spt6 interaction, but defects outside this interface can also cause
additive growth defects.
Another strategy for determining the importance of the Spn1-
Spt6 interface is to test the effect of overexpressing one partner.
If decreased affinity of Spt6-F249K protein for Spn1 is respon-
sible for growth defects in vivo, these defects might be
suppressed by increasing the level of Spn1 protein. We tested
this by transforming an spt6-F249K strain with high-copy plas-
mids containing variants of SPN1. As shown in Figure 5C,
increasing the level of normal SPN1 suppressed the temperature
sensitivity and partially corrected the Spt! phenotype caused by
spt6-F249K. Consistent with retention of partial binding, overex-
pression of spn1-R263D also had an effect but suppressed less
efficiently, rescuing growth at 36" but not at 38" and having no
effect on the Spt! phenotype. Spn1-K192N is not active at
elevated temperatures (Zhang et al., 2008; and Figure 5A), and
overexpression of this allele also did not rescue the phenotypes
caused by spt6-F249K. Elevated SPN1 copy number did not
suppress the temperature sensitivity or Spt! phenotypes caused
by the spt6-1004 allele (data not shown), which is a deletion of
the helix-hairpin-helix domain within the Tex-like core of Spt6
(Kaplan et al., 2005). The suppression of spt6 defects by
increased Spn1 is therefore at least partly specific for a mutation
that alters the Spn1-Spt6 interface, and supports the importance
of this interaction in an essential function in vivo.
Spt6 Binds Nucleosomes Directly and Is Inhibited
by Spn1
Spt6 has been shown to bind both (H3-H4)2 tetramers and H2A-
H2B dimers (Bortvin and Winston, 1996), leading to models in
which Spt6 acts as a histone chaperone during nucleosome
eviction and redeposition. Following our earlier prediction (John-
son et al., 2008) that the N-terminal region of Spt6 binds nucleo-
somes, we examined purified Spt6 constructs for nucleosome-
binding activity in an electrophoretic mobility shift assay
(EMSA). Interestingly, we found that intact Spt6 does bind nucle-
osomes in this assay (Figure 6), but does so only in the presence
of the small HMGB family member Nhp6 (Stillman, 2010). This is
similar to the requirement for addition of Nhp6 to observe
complexes between nucleosomes and a different histone chap-
erone, FACT (Formosa et al., 2001). As with FACT, this suggests
that Spt6 may form stable complexes with nucleosomes only
after the nucleosome has been partially destabilized by Nhp6.
This requirement appears to be physiologically relevant,
because loss of Nhp6 in vivo exacerbated the growth defects
caused by any of several mutations in Spt6 (Figure 5C, Fig-
ure S4A). Histone chaperones do not necessarily bind intact
nucleosomes; in fact, the Asf1-(H3-H4) interaction is incompat-
ible with histone contacts within the nucleosome (Antczak
et al., 2006; English et al., 2006; Natsume et al., 2007). Binding
to both free histones and to nucleosomes therefore might indi-
cate that Spt6 makes multiple distinct contacts with nucleo-
somes and their components during different steps in chromatin
maintenance. Spt6(239–1451) bound nucleosomes while Spt6
(315–1451) did not (Figure 6, compare lanes 2 and 3). Thus, the








Beamline SSRL 9-2 Home source Home source
Space group P3112 P3212 P21212
Unit cell dimensions
a, b, c (A˚) 61.9, 61.9, 240.4 61.3, 61.3, 116.05 105.9, 68.7, 73.9
a, b, g (") 90, 90, 120 90, 90, 120 90, 90, 90
Resolution (A˚) 35–3.0 30–2.15 30–2.15
Wavelength (A˚) 0.97923 (Peak) 1.54178 1.54178
I/sI 23.2 (2.8) 22 (4.1) 19.7 (3.1)
Completeness (%) 90.8 (92.3) 99.8 (98.4) 100.0 (100.0)
Rsym (%) 5.2 (47.6) 6.1 (31.9) 6.4 (54.4)
Redundancy 4.2 (4.1) 5.8 (3.8) 5.3 (5.0)
Refinement
Resolution (A˚) 29.6–2.15 27.7–2.15
Number of reflections 13,847 30,096
Rwork/Rfree (%) 18.5/22.4 18.6/24.4
Number of protein atoms 1,216 2,903
Number of solvent atoms 144 268
Rmsd bond lengths (A˚)/angles (") 0.007/1.001 0.012/1.279
4/c most favored/allowed (%) 99.3/100.0 99.2/100.0
Values in parentheses are for the highest-resolution shell.
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region of Spt6 required for nucleosome binding (residues 239–
314) contains the region required for Spn1 binding (239–268),
suggesting that these two interactions may be mutually
exclusive.
Consistent with this possibility, adding Spn1(120–410) to the
nucleosome-binding assay inhibited the formation of Spt6-
nucleosome complexes (Figure 6, compare lanes 2 and 5).
Spn1 did not form stable complexes with nucleosomes itself,
so the inhibition is unlikely to be caused by competition between
Spn1 andSpt6 for a common binding site on nucleosomes. Spn1
did not interact with Nhp6 genetically (Figures S4B and S4C),
and inhibition of Spt6-nucleosome complex formation by Spn1
could not be overcome by increasing the concentration of
Nhp6 (data not shown), making it unlikely that the inhibition is
caused by sequestering of Nhp6 by Spn1. Instead, Spn1
appears to prevent Spt6 from binding to nucleosomes directly
by blocking the Spt6 binding domain. Supporting this interpreta-
tion, the Spn1-R263D variant with reduced affinity for Spt6 did
not block formation of Spt6-nucleosome complexes efficiently
(Figure 6, lane 7). Further, the Spt6-F249K mutation affects
a region important for both nucleosome binding and Spn1 inter-
action (Figures 4 and 6, compare lanes 2 and 8). Spt6-F249K
protein was impaired for nucleosome binding, but the residual
binding was partially resistant to the addition of Spn1 (Figure 6,
lanes 8 and 9). These results show that Spt6 residue F249
contributes to both nucleosome binding and to Spn1 binding,
and that Spn1 binding can block an interaction between Spt6
and nucleosomes. The Spn1-Spt6 interaction can therefore
provide a switch that controls the interaction of Spt6 with nucle-
osomes, and the proper functioning of this switch is important for
maintaining normal chromatin structure.
DISCUSSION
We have determined a crystal structure of the ordered central
domain of Spn1 and shown that it binds a 30 residue segment
of Spt6. We have also determined a crystal structure of an
Spn1-Spt6 complex that reveals that Spt6 binds in an
extended/helical conformation that drapes the Spt6 residues
along one face of Spn1. We further used site-directed mutations
to disrupt this interaction and demonstrated that the interaction
observed in solution depends on residues located at the inter-
face seen in the crystal structure. Binding is not accompanied
by conformational changes in Spn1. In contrast, Spt6(239–268)
is almost certainly unstructured in isolation and becomes
ordered upon binding Spn1. Indeed, the first 300 residues of
Spt6 are likely to be unstructured in isolation (Ward et al.,
2004), whereas much of the remainder of the protein appears
to comprise multiple recognizable structural domains that likely
fold against each other to form an elongated structure (Johnson
et al., 2008). The extended and inherently flexible nature of the
Spn1 binding sequence of Spt6 presumably explains why
dramatic mutations in the interface substantially weaken but
do not completely eliminate this interaction, as localized pertur-
bations can be accommodated by conformational changes that
do not propagate across the entire interface. Moreover, the !35
residues separating the Spn1-binding residues from the ordered
Figure 4. Mutations at the Spn1-Spt6 Interface Disrupt Binding
In Vitro
Representative ITC binding isotherms for the indicated mutant Spt6(239–268)
and Spn1(148–293) proteins, Spt6-F249K (diamonds), Spn1-R263D (circles),
and Spn1-F267E (squares). A WT isotherm is shown for reference (triangles).
See text and Table S1 for thermodynamic parameters.
Figure 3. Details of the Spn1-Spt6 Interface
Stereoview of the Spn1-Spt6 interface. Residues mutated in this study are
indicated in bold font and underlined. Water molecules are shown as red
spheres, and polar interactions are indicated by black dashes.
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Figure 5. The Spn1-Spt6 Interaction Is Significant for the Essential Activities of Each Protein In Vivo
(A) Isogenic strains from the A364a genetic background and with the relevant genotypes indicated (Supplemental Information) were grown to saturation in rich
medium, then aliquots of 10-fold serial dilutions were placed on solid medium and incubated as labeled. SC is synthetic medium (complete or lacking tryptophan
or lysine as noted) and YPAD is richmedium. Growth onmedium lacking lysine reveals the Spt! phenotype, reporting here on aberrant transcription initiation from
the lys2-128v allele. The strain with the spt6-F249K allele grows slowly on SC –lys at 25", but the Spt! phenotype is more robust at 30" (B).
(B) WT and spt6-F249K strains were transformed with a high-copy number vector or the same vector carrying the version of SPN1 noted (Supplemental Infor-
mation). Multiple transformants were tested to insure that the phenotypes detected are typical, then one clone of each was grown to saturation in synthetic
medium lacking tryptophan to select for retention of the plasmids. Aliquots of 10-fold serial dilutions were placed on solid synthetic medium as in (A) and incu-
bated as indicated.
(C) As in (A). nhp6-D indicates deletion of both NHP6A and NHP6B.
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region of Spt6 likely provide a tether whose flexibility may be
required to allow the Spn1-Spt6 complex to form in multiple
functional contexts.
Spt6 and Spn1 were found to copurify in high-throughput
screens (Gavin et al., 2002; Krogan et al., 2002), and further
studies suggested that their interaction promotes normal activa-
tion of genes regulated after recruitment of RNAPII (Fischbeck
et al., 2002; Yoh et al., 2007; Zhang et al., 2008). However,
Spt6 and Spn1 have also been implicated in several other
distinct and overlapping roles, and each has been implicated
in interactions with multiple factors. We have verified a functional
interplay between Spt6 and Spn1 proteins in S. cerevisiae by
demonstrating that cells cannot tolerate certain partial loss-of-
function alleles of both genes simultaneously, and by showing
that the defects caused by the spt6-F249K allele, which impairs
binding with Spn1, can be suppressed by overexpressing SPN1.
Our results therefore show that a short region of Spt6 is impor-
tant for interacting with Spn1 during at least one of the essential
processes mediated by these proteins.
One of the primary functions ascribed to Spt6 is as a histone
chaperone that promotes the reassembly of nucleosomes
following passage of RNAPII (Adkins and Tyler, 2006; Bortvin
and Winston, 1996; Cheung et al., 2008; Kaplan et al., 2003).
Spt6 was previously shown to bind histones and to promote
nucleosome deposition in vitro (Bortvin and Winston, 1996),
and we now show that it can also bind to intact nucleosomes.
The dependence of this interaction upon the presence of Nhp6
is consistent with our genetic studies and with an equivalent
dependence of the unrelated FACT histone chaperone for its
interaction with intact nucleosomes (Formosa et al., 2001). We
found that nucleosome binding requires a section of Spt6 that
overlaps with the Spn1 binding site, that Spn1 antagonizes
Spt6-nucleosome binding in vitro, that either SPT6 or SPN1
mutations that affect the Spn1-Spt6 interaction cause the Spt!
phenotype, and that the effects of the spt6-F249K allele can be
suppressed by overexpressing Spn1. These results show that
the Spn1-Spt6 interaction disrupts Spt6-nucleosome binding
and that this disruption has a positive role in maintaining normal
chromatin. An attractive explanation is that Spn1 is actively
engaged in the nucleosome reassembly process, possibly by
disengaging Spt6 from nucleosomes to allow multiple rounds
of reassembly (see the graphical abstract available online).
Another possibility is that Spn1 binding influences the balance
between Spt6’s functional roles in nucleosome reassembly
and mRNA processing. Regardless of the precise mechanistic
details, Spn1 appears to be important for Spt6-mediated nucle-
osome reassembly in vivo.
Nucleosome reassembly is just one of several processes in
which Spt6 and Spn1 have been implicated. For example,
Spn1, in complex with Spt6, has been reported to interact with
a variety of other factors that function in mRNA processing,
nucleosome modification, or transcription, including REF1/Aly,
Setd2, and RNAPII (Yoh et al., 2007, 2008; Zhang et al., 2008).
Our structural data provide insight into how Spn1 might accom-
modate simultaneous interactions. Spt6 binds against a region
of the Spn1 surface that is rich in conserved residues, but other
regions of Spn1 display a similar level of conservation and are
therefore good candidates for binding surfaces for other proteins
(Figure 2C, Figure S1C). This includes residues that are immedi-
ately adjacent to the Spt6 binding surface but extend beyond
contacts with Spt6, which may indicate that other factors can
bind Spn1 cooperatively or competitively with Spt6. Finally,
K192, whose mutation to asparagine impairs Spn1 function
(Zhang et al., 2008) and appears to function in interactions with
RNAPII, is located in a conserved pocket that is formed at the
ends of H1, H2, and H4 (Figures 2B and 2C), suggesting another
potential binding surface.
In summary, we have determined the structural basis for the
interaction between Spn1 and Spt6, and shown that this interac-
tion is important in vivo and that it regulates Spt6-nucleosome
binding in vitro. Overall, our data indicate that Spn1 is important
for Spt6-mediated nucleosome reassembly, perhaps by regu-
lating the process or by providing a switch that drives disengage-
ment. This does not, however, seem to encompass all of the
functional roles in which these two proteins and their interaction
with each other participate (Lindstrom et al., 2003; Yoh et al.,
2007, 2008; Zhang et al., 2008). Sequence conservation indi-
cates that other surfaces on the Spn1 core domain are good
candidates for mediating functionally important interactions.
Moreover, interactions with Setd2 and REF1/Aly have been
mapped to the N- and C-terminal regions, respectively, which
extend beyond the Spn1 core domain and are predicted to be
Figure 6. Spt6 Binds Nucleosomes and Is Competed by Spn1
EMSA visualizing the signal from the labeled DNA incorporated into the nucle-
osomes (Cy5, 633 nm). All reactions included 150 fmoles of nucleosomes,
3 mM Nhp6, and 2 mM of the indicated Spt6 or Spn1 proteins. Migration posi-
tions of bound and unbound nucleosomes are indicated. Addition of Spn1
reduced the amount of Spt6-nucleosome complex from 37%of the total signal
in lane 2 to 3.2% in lane 5 (9% remaining), but Spn1-R263D only reduced it to
28% (76% remaining). Spt6-F249K formed a lower amount of stable complex
(18%), but Spn1 was less effective at inhibiting this (6% bound, or 36% of the
original signal remaining comparing lanes 8 and 9) than it was with WT Spt6
(9% of the original signal remaining).
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unstructured (Ward et al., 2004; Yoh et al., 2007, 2008). This use
of inherently flexible segments, including theN-terminal region of
Spt6 that binds the Spn1 core, may provide a mechanism that
allows flexibility in a crowded transcriptional environment.
EXPERIMENTAL PROCEDURES
See the Supplemental Information for protein expression and purification,
strains used, strain construction, plasmid construction, and tests of the effects
of combining spn1 and spt6 mutations.
Crystallization and Structure Determination
All crystals were grown at 20!C by sitting drop vapor diffusion. Se-Spn1
(148–307) drops comprised 2 ml of 8 mg.mL"1 protein with 2 ml of well solution
(0.1 M Bis-Tris propane [pH 7.0], 1.4 M Li2SO4). Native Spn1(148–307) drops
comprised two parts 7.5 mg.mL"1 protein and one part well solution (0.01 M
MgCl2, 0.05 M HEPES [pH 7.0], 1.6 M [NH4]2SO4). Spn1(148–293)-Spt6(239–
268) drops comprised two parts 13mg.mL"1 protein and one part well solution
(0.2 M Mg[CH3CO2]2, 0.1 M MES [pH 6.5], 20% PEG 8000). Crystals were
cryoprotected in a solution of the reservoir made up with 30% glycerol, and
cooled by plunging into liquid nitrogen.
All data were processed using HKL2000 (Otwinowski and Minor, 1997).
Phases were determined for Se-Spn1(148–307) by single-wavelength anoma-
lous diffraction. Phenix (phenix.autosol) (Adams et al., 2010) located four out of
six possible selenium positions and computed a map into which a model was
built. This unrefined model was used in molecular replacement using PHASER
(McCoy et al., 2005) to determine the structure of native Spn1(148–307) at
2.15 A˚ resolution. This subsequently refined model was used to determine
the Spn1(148–293):Spt6(239–268) structure by molecular replacement. In all
cases, model building, refinement,and validation were performed using Coot
(Emsley et al., 2010), Phenix (Adams et al., 2010), and MolProbity (Chen
et al., 2010), respectively. Refinement of the Spn1(148–293)-Spt6(239–268)
complex included TLS restraints (Painter and Merritt, 2006).
Electrostatic potential surfaces were calculated using APBS (Baker et al.,
2001). Figures of molecular structures were generated using PyMol (DeLano,
2002).
Size-Exclusion Chromatography Binding Assay
Purified recombinant proteins were mixed at equimolar concentrations (2 mM)
and incubated for 2 hr at 4!C. The protein mixture was concentrated to 15 mM
and chromatographed on a 120 ml Superdex 200 16/60 column (GE Health-
care) in 15 mM Tris (pH 7.5), 200 mM NaCl, 5% glycerol, 0.5 mM EDTA, and
2 mM 2-mercaptoethanol.
Isothermal Titration Calorimetry
Amino acid substitutions weremade by site-directed mutagenesis and verified
by DNA sequencing. Purified recombinant proteins were dialyzed overnight at
4!C against 2 L of degassed ITC buffer (20mMTris [pH 7.5], 150mMNaCl, 5%
glycerol, 2 mM 2-mercaptoethanol, 0.5 mM EDTA). Titrations for all reactions
were done at 25!C on an iTC200 (Microcal), including an initial injection of
0.4 ml (which was omitted from data analysis), and all injections were spaced
180 s apart. For Spt6(239–1117) reactions, the titrations were carried out
with 18 injections of 1.8 ml 76 mM Spn1(148–293) into 8.2 mM Spt6(239–
1117). For Spt6(239–268) reactions, the titrations were with 18 injections of
2 ml 74 mMSpt6(239–268) into 8 mMSpn1(148–293). For Spt6-F249K reactions,
the titrations were with 18 injections of 1.8 ml 1.52 mM Spt6(239–268)-F249K
into 168 mM Spn1(148–293). For Spn1-R263D reactions, the titrations were
with 18 injections of 1.8 ml 3.5 mM Spt6(239–268) into 389 mM Spn1(148–
293)-R263D. For Spn1-F267E reactions, the titrations were with 18 injections
of 2.0 ml 5.2 mM Spt6(239–268) into 578 mM Spn1(148–293)-F267E). In all
cases, three independent experiments were performed. Data were analyzed
using Origin software (Microcal), and the stoichiometry (N), association
constant (KA), and change in enthalpy (DH) were obtained by fitting the
isotherm to the one-site binding model. Other thermodynamic parameters
were calculated using the following relationships:
K"1A = KD and " RT lnKA = DH " TDS:
Nucleosome Preparation and Gel Mobility Shift Binding Assay
A 146 bp sea urchin 5S rDNA fragment labeled with Cy5 was generated by
PCR and gel purified. Xenopus laevis histone H2A-S113C was labeled with
Oregon Green 488-maleimide and then assembled into nucleosome core
particles as described (Xin et al., 2009). Reactions contained 15 nM nucleo-
somes, 2 mMSpt6 or Spn1 proteins, 100mMNaCl, 0.8 mg/ml HSA, 9.7% glyc-
erol, and 3 mM S. cerevisiae Nhp6a. Following incubation at 30!C for 15 min,
samples were subjected to electrophoresis on native polyacrylamide gels
(4.5% acrylamide [acr:bis, 37.5:1], 0.5 X TBE, 5% glycerol, 2 mM MgCl2 at
160 V for 6 hr at 4!C). The gels were scanned using a Typhoon imager at
670 BP30/Red(633 nm) for Cy5-DNA and 520 BP40/Blue(488 nm) for Oregon
Green 488-H2A, and the amount of signal in the bound form quantified with
ImageQuant Software (GE Health Sciences).
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Note Added in Proof
An independent study (M.-L. Diebold, M. Koch, E. Loeliger, V. Cura, F. Win-
ston, J. Cavarelli, and C. Romier, EMBO J, 10.1038/emboj.2010.272) has
also determined a very similar structure of a Spn1-Spt6 complex; the results
of the two studies are highly complementary.
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MECHANISM OF HISTONE CHAPERONE ACTIVITY OF  
 





Spt6 is a histone chaperone that binds and reassembles nucleosomes in 
the wake of elongating RNAPII.  This activity is essential to restore the default 
repressive chromatin state and to prevent inappropriate transcription initiation. 
Nucleosome binding by Spt6 requires a region of the protein that overlaps with 
the Spn1-binding site, and the Spn1-Spt6 interaction antagonizes Spt6-
nucleosome binding in vitro.  In an effort to further understanding of the molecular 
details of the histone chaperone activity of Spt6, we have performed a number of 
direct binding and competition assays.  These data reveal that Spt6 is able to 
bind both histone H3-H4 tetramers [(H3-H4)2] and H2A-H2B dimers, although the 
mode of interaction between Spt6 and each of the two histone subcomplexes 
appears to be different.  The interaction with (H3-H4)2 is primarily hydrophobic in 
nature while the interaction with H2A-H2B is largely electrostatic.  Competition 
experiments demonstrated that the Spn1-Spt6 and Spt6-(H3-H4)2 interactions 
are mutually exclusive.  We further demonstrated that the Spn1-binding-motif of 
Spt6 (Spt6-SBM, residues 239-268) is necessary and sufficient for histone 
binding, that Spt6 recognizes the ordered histone core of both subcomplexes, 
and that Spt6 competes with DNA for histone binding.  Overall, the data 
presented in this chapter strongly support our previous hypothesis that Spn1 
plays a regulatory role in the histone chaperone activity of Spt6, and suggest a 





Eukaryotic organisms have evolved an effective DNA packaging system, 
collectively known as chromatin, which consists of four core histone proteins 
(H2A, H2B, H3 and H4) as well as linker histones and other factors (Li and 
Reinberg, 2011).  This system allows organisms to compact their large genomes 
and fit them into the nucleus of each cell.  It is not simply enough to package 
efficiently, however, because much of the DNA needs to be accessed on a 
regular basis, and the packaging therefore must be dynamic.  For example, every 
time a cell divides the entire genome must be replicated.  Similarly, the synthesis 
of RNA and protein molecules that drive cellular processes requires accessing, 
processing, and repackaging relevant segments of the genome.  Thus, 
packaging, accessing, and repackaging of genomic DNA is intimately linked to 
biological function and is highly regulated.  
The fundamental DNA packaging unit in eukaryotic cells is called the 
nucleosome, which consists of nearly 150 base pairs of DNA wrapped twice 
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around a protein core made of two copies each of the four core histone proteins 
(Luger et al., 1997).   Individual nucleosomes are separated by a short DNA 
linker, which allows the nucleosomes to further associate with protein partners 
and wind around each other to establish a higher level of compaction (Li and 
Reinberg, 2011; Saunders et al., 2006).  
In a simplistic transcription model, there are two different classes of 
proteins or protein complexes that mediate access to DNA by RNA polymerase II 
(RNAPII).  In one case, enzymatic protein complexes called chromatin 
remodelers use the energy of ATP binding and hydrolysis to drive a motor-like 
ratchet system that can translocate DNA with respect to the nucleosomal 
histones or even eject histones completely (Cairns, 1998; Clapier and Cairns, 
2009).  In the other case, histone chaperone proteins use inherent binding 
energy to displace histones from intimate contact with the DNA and/or 
reassemble nuclesomes after the DNA has been accessed (Andrews et al., 2010; 
Winkler et al., 2011). The Spt6 protein falls into the latter category of histone 
chaperones.   
The essential and conserved Spt6 protein is implicated in a multitude of 
chromatin-associated events including transcription initiation (Adkins and Tyler, 
2006; Cheung et al., 2008; Kaplan et al., 2003), transcription elongation by RNA 
polymerase I (Beckouet et al., 2011) (RNAPI) and RNAPII (Ardehali et al., 2009; 
Endoh et al., 2004; Hartzog et al., 1998; Kaplan et al., 2005; Kaplan et al., 2000; 
Keegan et al., 2002; Lindstrom et al., 2003; Yoh et al., 2007), silencing of 
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heterochromatin (Kiely et al., 2011), class-switch recombination of Ig genes 
(Okazaki et al., 2011), various transcription-directed signaling pathways 
(Baniahmad et al., 1995; Kok et al., 2007; Li et al., 2010; Nishiwaki et al., 1993; 
Shen et al., 2009; Widiez et al., 2011), and mRNA maturation and export 
(Andrulis et al., 2002; Bucheli and Buratowski, 2005; Burckin et al., 2005; Kaplan 
et al., 2005; Yoh et al., 2007).  Spt6 appears to accomplish these feats through 
direct and indirect binding events with an array of factors, including RNAPI 
(Beckouet et al., 2011) and RNAPII (Diebold et al., 2010; Lindstrom et al., 2003; 
Sun et al., 2010; Yoh et al., 2007; Yoh et al., 2008), histones H3 and H4 (Bortvin 
and Winston, 1996), nucleosomes (McDonald et al., 2010), DNA (Close et al., 
2011), and various transcription factors (Andrulis et al., 2002; Gavin et al., 2002; 
Lindstrom et al., 2003).  The Saccharomyces cerevisiae Spt6 protein is large 
(~168 kDa) and folds into six recognizable structural domains with homology to 
known DNA binding and protein-protein interaction motifs, and has an acidic, 
disordered N-terminal region of ~300 amino acid residues (Close et al., 2011).  
This makes it easy to imagine Spt6 serving as a docking platform in elongation 
complexes, where its multiple domains are responsible for recruiting a variety of 
factors and binding RNAPII.  The inherent disorder of the acidic N-terminal region 
of Spt6, including the segment required for binding Spn1, may provide the 
necessary flexibility required for function in a crowded transcriptional 
environment. Delineation of the intricacies of the various Spt6 interaction 
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networks and correlation with the numerous regulatory and transitional steps in 
gene expression is an important remaining obstacle in this field.   
Nucleosome reassembly mediated by Spt6 has profound regulatory 
effects at both intergenic and intragenic start sites (Cheung et al., 2008; Kaplan 
et al., 2003) and is likely to be a result of direct interactions with histones and 
perhaps DNA.  In vitro, Spt6 promotes histone deposition on plasmid DNA, and 
directly binds DNA, nucleosomes, and free histones with a preference for binding 
the histone H3-H4 tetramer (Bortvin and Winston, 1996; Close et al., 2011; 
McDonald et al., 2010). Our previous biochemical and genetic studies on this 
process (see Chapter 3) have found that the ability of Spt6 to bind nucleosomes 
is dependent on the small HMGB family member Nhp6, which is thought to bind 
DNA and weaken the interactions between the DNA and histones within a 
nucleosome (Stillman, 2010).  The ability of the unrelated histone chaperone 
FACT to make complexes with nucleosomes is also dependent on Nhp6 
(Formosa et al., 2001).  This implies that the histone chaperone activity of Spt6 is 
likely to involve direct interactions with histones, that the interface may at least 
partially overlap with the histone-DNA interface, and that this may be a common 
mode of action for other histone chaperones. Nucleosome binding by Spt6 
requires a region of the protein that overlaps with the Spn1-binding site, and the 
Spn1-Spt6 interaction antagonizes Spt6-nucleosome binding in vitro.  Mutations 
in SPT6 or SPN1 that disrupt the Spn1-Spt6 interaction cause the Spt- 
phenotype, and the effects of the spt6-F249K allele are suppressed by 
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overexpressing Spn1. This shows that the Spn1-Spt6 interaction disrupts Spt6-
nucleosome binding and that this disruption has a positive role in maintaining 
normal chromatin. An attractive explanation is that Spn1 is actively engaged in 
the nucleosome reassembly process, possibly by disengaging Spt6 from 
nucleosomes to allow multiple rounds of reassembly.  Another possibility is that 
Spn1 binding influences the balance between Spt6ʼs functional roles in 
nucleosome reassembly, transcription elongation, and mRNA processing.  
Regardless of the precise mechanistic details, Spn1 appears to be important for 
Spt6-mediated nucleosome reassembly in vivo. 
In order to gain insight into the molecular details of the histone chaperone 
activity of Spt6, and to assess the potential regulatory role of Spn1 in this 
process, we utilized a number of biochemical binding and competition assays.  
The data presented in this chapter confirm that Spt6 binds directly to both histone 
H3-H4 tetramers [(H3-H4)2] and H2A-H2B dimers, that Spn1 directly competes 
with histones for Spt6 binding, and that Spt6 competes directly with DNA for 
histone binding.  Overall, these data strongly support our previous hypothesis 
that Spn1 plays a regulatory role in the histone chaperone activity of Spt6, and 
demonstrate that Spt6 utilizes a direct DNA-competition mechanism for 
chaperoning histones similar to other well-characterized histone chaperones 
Nap1 and FACT. 
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Results and Discussion 
 
Spt6 binds both histones (H3-H4)2 and H2A-H2B 
 
 Full-length Spt6 protein with an N-terminal GST fusion does not express in 
bacterial cells; therefore, we utilized an N-terminal GST fusion to an N-terminal 
truncation of Spt6 (residues 239-1451), which retains nucleosome binding, to 
assess binding to the two different histone subcomplexes, histone H3-H4 
tetramers [(H3-H4)2] and H2A-H2B dimers.  It is important to note that the 
different recombinant histone subcomplexes at concentrations typical of 
biochemical assays (1-50 µM) differ in their stability and solubility; H2A-H2B is 
tolerant of low salt buffers that mimic physiological conditions while (H3-H4)2 
begins to precipitate out of solution in buffers below 500 mM sodium chloride.  
We performed GST-pulldown assays and found that GST-Spt6(239-1451) binds 
both histone subcomplexes (Figure 4-1A and B, top panels are elutions from the 
GST beads after washing).  Binding to (H3-H4)2 was assessed under high salt 
conditions (750 mM NaCl) in order to prevent nonspecific binding (Figure 4-1A, 
lane 4), as well as to keep (H3-H4)2 stable and in solution during the binding 
reactions.  Binding of GST-Spt6(239-1451) to Spn1 was used as a positive 
control under the same high salt conditions (Figure 4-1A, lane 6).  In Figure 4-1A, 
lanes 3 and 4 clearly show that neither (H3-H4)2 or Spn1 bind nonspecifically to 
GST or the glutathione resin (compare top panel elutions to bottom panel inputs).  
GST-Spt6(239-1451) clearly bound both Spn1 and (H3-H4)2 in separate 
reactions (Figure 4-1A, lanes 6 and 7, top panel), indicating that the Spn1-Spt6 
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!Figure 4-1.  Spt6 binds directly to both histone tetramers and 
dimers. 
A) GST-pulldowns with GST-Spt6(239-1451) show direct binding to 
tetrameric histones (H3-H4)2.  Top panels are elution samples after 
washing with high salt (750 mM NaCl) binding buffer.  Bottom panels are 
input samples of the reactions prior to addition of glutathione resin.  
Migration positions of the different proteins are indicated.  Lane 1, protein 
standards; Lane2, GST alone; Lane 3, GST binding negative control with 
Spn1; Lane 4, GST binding negative control with (H3-H4)2; Lane 5, GST-
Spt6(239-1451) alone; Lane 6, GST-Spt6 binding positive control to 
Spn1; Lane 7, GST-Spt6 binding to (H3-H4)2.  
B) As in (A), GST-pulldowns with GST-Spt6(239-1451) show direct 
binding to dimeric histones H2A-H2B. Lane 1, protein standards; Lane2, 
GST alone; Lane 3, GST binding negative control with H2A-H2B in low 
salt buffer; Lane 4, GST binding negative control with H2A-H2B in high 
salt buffer; Lane 5, GST-Spt6(239-1451) alone; Lane 6, GST-Spt6 
binding to H2A-H2B in low salt buffer; Lane 7, GST-Spt6 binding to H2A-
H2B in high salt buffer.  
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interaction and the Spt6-(H3-H4)2 interaction are both highly specific, robust, and 
strongly hydrophobic.  Histone H2A-H2B dimers showed no nonspecific 
background binding to free GST or the glutathione resin in low salt (200 mM 
NaCl) or high salt buffers (Figure 4-1B, lanes 3 and 4).  GST-Spt6(239-1451) 
bound H2A-H2B in low salt buffer; however, the interaction was severely 
perturbed in the high salt buffer (Figure 4-1B, compare lanes 6 and 7, top panel), 
indicating the interaction is primarily of an electrostatic nature.  These data 
support a model in which Spt6 can chaperone both histone subcomplexes, but 
indicate that Spt6 utilizes a different mode of interaction with each subcomplex, 
perhaps providing some specificity in nucleosome reassembly during 
transcription elongation.  Consistent with this, Spt6 also promotes deposition of 
histones onto plasmid DNA (Bortvin and Winston, 1996), therefore, Spt6 may be 
capable of chaperoning both histone subcomplexes.  Further, other histone 
chaperones such as Nap1, Vps75, and FACT have been found to bind and 
promote the DNA deposition of both histone subcomplexes (Andrews et al., 
2010; Bowman et al., 2011; Formosa, 2012; Su et al., 2011), suggesting that a 
common mechanism may be used by different histone chaperones that function 
in the dynamic chromatin environment.  
 
Spn1 directly competes with histones for Spt6 binding 
 We have shown previously that an Spt6 construct with a deletion of the 
first 238 N-terminal residues (Spt6(239-1451)) can bind nucleosomes in the 
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presence of Nhp6 (McDonald et al., 2010).  An Spt6 construct with a deletion of 
the first 314 N-terminal residues (Spt6(315-1451)) was unable to bind 
nucleosomes, suggesting that Spt6 may utilize a small region of its acidic N-
terminus to bind both Spn1 and histones.  Indeed, Spn1 blocked the 
nucleosome-Spt6 interaction in nucleosome binding assays.   
We have extended this observation by performing a direct competition 
GST-pulldown assay between GST-labeled Spn1(148-307), Spt6(239-1451) and 
(H3-H4)2 (Figure 4-2).  In this assay, a high salt buffer (750 mM NaCl) was again 
used to minimize nonspecific binding of histones to GST and the glutathione 
resin and maintain the stability and solubility of (H3-H4)2 (Figure 4-2, lane 4).  In 
the competition reactions, the concentrations of GST-Spn(148-307) and 
Spt6(239-1451) are maintained at a constant value of 5 µM, while the 
concentration of (H3-H4)2 was increased in 2-fold increments from 1.5 µM to 50 
µM in lanes 8 through 13.  There were no nonspecific interactions observed 
between GST or the glutathione resin and either Spt6(239-1451) or the highest 
concentrations of histones (Figure 4-2, lanes 3 and 4).  GST-Spn1(148-307) 
bound Spt6 in each reaction of this assay (Figure 4-2, lanes 6 and 8 through 13), 
but failed to make a ternary complex with Spt6 and histones (Figure 4-2, lanes 8 
through 13), even at the highest histone concentration tested, which was 10-fold 
greater than the Spt6 and Spn1 concentrations (Figure 4-2, lane 13, 50 µM 
histones vs. 5 µM Spt6 and Spn1).  Spn1 appears to prevent the histones from 
binding Spt6 in this assay, which strongly implies that the Spn1-Spt6 interaction 
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!Figure 4-2.  Spn1 blocks histones (H3-H4)2 from binding Spt6 
GST-pulldowns were performed as in figure 4-1A (high salt buffer) using 
GST-Spn1(148-307) and untagged Spt6(239-1451) and (H3-H4)2.  Lanes 
1 through 5 are controls as in figure 4-1A; Lane 6, GST-Spn1 positive 
control binding to Spt6(239-1451); Lane 7, GST-Spn1 negative control 
binding to (H3-H4)2; Lanes 8-13; GST-Spn1 binding to Spt6 in the 




























































































and the Spt6-(H3-H4)2 interaction are mutually exclusive.  This also indicates the 
Spt6 likely utilizes its Spn1-binding-motif (SBM, residues 239-268) to bind both 
histones and Spn1.  These data provide strong supportive evidence that Spn1 
does indeed play a regulatory role in the histone chaperone activity of Spt6 by 
directly competing for Spt6 binding with histones.  
 
The Spt6-SBM is necessary and sufficient for binding (H3-H4)2 
 In order to further address the importance of the Spt6-SBM in binding 
histones, we determined that the Spt6-SBM was necessary for binding histones 
using three different Spt6 constructs (Figure 4-3A and B).  Two of these 
constructs were N-terminal truncations that removed either the first 238 residues 
(residues 239-1117, keeping the SBM intact), or the first 276 residues of the N-
terminus (residues 277-1117, removing the SBM).  The other was a deletion 
construct within the context of the full-length protein, Spt6(∆239-268), which 
specifically deletes only the SBM.  We were unable to test binding to the WT full-
length Spt6 protein due to lack of solubility at the high concentrations needed for 
these assays.  We measured the equilibrium binding constants, KD, between 
each Spt6 construct and fluorescently labeled (H3-H4)2 using a slightly modified 
version of the fluorescence assay developed in the Luger laboratory.  Instead of 
just measuring a change in fluorescence intensity upon titration of the unlabeled 
binding partner, we measured parallel and perpendicular intensities and 
calculated the change in anisotropy (LiCata and Wowor, 2008) to quantify binding 
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!Figure 4-3.  The spn1-binding-motif (SBM, residues 239-268) of Spt6 
is necessary and sufficient to bind histones (H3-H4)2.  
A) Fluorescence anisotropy measurements under high salt conditions 
(750 mM NaCl) indicate binding between Spt6 and fluorescently labeled 
(H3-H4)2 requires the presence of the Spt6-SBM.  Binding isotherms are 
shown for each Spt6 protein construct tested, Spt6(239-1117) closed 
circles, Spt6(277-1117) open circles, and Spt6(!239-269) open squares.  
Error bars are ± standard error from at least three independent 
measurements.  Affinity values are indicated. 
B) As in (A), fluorescence anisotropy measurements with fluorescently 
labeled Spt6-SBM (Spt6(239-268)) binding to unlabeled (H3-H4)2 
indicate that the Spt6-SBM is suffucuent to recapitulate the binding 
energy of larger Spt6 constructs.   
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labeled with OG-488 




labeled with OG-488 
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of Spt6 to histones.  Again, a high salt (750 mM NaCl) buffer was used to prevent 
any nonspecific histone interactions and to maintain the stability and solubility of 
the histones.  Binding between the two Spt6 constructs lacking the SBM 
(Spt6(277-1117) and Spt6(∆239-268)) and (H3-H4)2 was reduced at least 20-fold 
compared to the Spt6 construct that contained the SBM (Spt6(239-1117), figure 
4-3A,  ~ 30 µM KD vs. 1.3 µM KD).  These data show that the Spt6-SBM is 
necessary to retain full binding to (H3-H4)2.  
We next sought to address whether the Spt6-SBM is sufficient for binding 
histones by fluorescently labeling recombinant Spt6-SBM and measuring binding 
affinity to unlabeled histones (Figure 4-3B).  In these assays (high salt buffer), 
the binding affinity between Spt6-SBM and (H3-H4)2 was essentially identical to 
the affinity between Spt6(239-1117) and (H3-H4)2 (KD = 1.1 µM vs. 1.3 µM for 
Spt6(239-1117)).  These data indicate that the Spt6-SBM is sufficient to 
recapitulate the binding energy of larger Spt6 constructs.  Taken together, this 
provides strong evidence that the Spt6-SBM is required for histone binding, and 
is consistent with a model in which Spn1 binding influences the nucleosome 
reassembly activity of Spt6. 
 
Spt6 binds the core ordered region of both histone subcomplexes 
 Each of the four core histone proteins has flexible N-terminal tails that are 
targets for a number of posttranslational modifications (Luger and Richmond, 
1998; Strahl and Allis, 2000).  As discussed in Chapter 1, these posttranslation 
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modifications are a result of various intracellular signaling pathways that 
ultimately provide a code determining the state of any given gene.  Certain 
modification combinations can yield an actively transcribed gene, while others 
suppress transcription (Strahl and Allis, 2000).  A number of protein domains are 
known to specifically recognize different chemical modifications on amino-acid 
sidechains, and thus, the code can be discerned and the signal relayed to the 
transcription machinery (Jenuwein and Allis, 2001; Ruthenburg et al., 2007; 
Taverna et al., 2007).  We were curious to know if the histone tails contributed to 
the interaction with Spt6, although primary sequence and secondary structural 
analyses did not indicate the presence of any known histone modification 
recognition domains (Maclennan and Shaw, 1993; McGuffin et al., 2000). 
 Tailless versions of all four histones were made that included H2A 
residues 14-118, H2B residues 24-122, H3 residues 27-135, and H4 residues 20-
102, and we assessed binding to Spt6 using the fluorescence anisotropy assay 
for (H3-H4)2 (Figure 4-4A) and a native gel shift binding assay for H2A-H2B 
(Figure 4-4B).  The tailless, or globular, H3-H4 tetramers [g(H3-H4)2] were 
fluorescently labeled as for the WT proteins, and unlabeled Spt6(239-1117) was 
titrated, with the reactions again performed in the high salt buffer (Figure 4-4A).  
The measured KD was 0.94 µM, which is nearly identical to the KD measured for 
full-length histone proteins (1.4 µM).  These results indicate that the tails of (H3-
H4)2 do not contribute to the binding of Spt6.   
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!Figure 4-4.  Histone tails do not contribute to the interaction with 
Spt6.  
A) Binding isotherms derived from fluorescence anisotropy 
measurements in high salt conditions (750 mM NaCl) indicate no loss of 
binding affinity between Spt6 and fluorescently labeled ‘tailless’ or g(H3-
H4)2 (open circles) compared to FL-(H3-H4)2 (closed circles, dashed 
line).  Error bars are ± standard error from at least three independent 
measurements.  Affinity values are indicated. 
B) Binding isotherms and affinity estimations from EMSA assays with 
Spt6-SBM and H2A-H2B (full-length, closed circles, dashed line; ‘tailless’ 
or gH2A-H2B, open circles) show no loss of binding affinity upon tail 
removal.  Affinity values are indicated. 
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!Binding to FL or g(H3-H4)2 
labeled with OG-488 
A
B
Binding to Spt6(239-268) 
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 Binding to tailless, or globular, H2A-H2B (gH2A-H2B) was assessed in low 
salt buffer (Figure 4-4B).  We attempted to use the fluorescence anisotropy 
assay; however, the results did not correlate with other quantitative binding 
assays using identical buffers.  We therefore used an electrophoretic mobility 
shift assay (EMSA) because the measured KD values using this assay with full-
length H2A-H2B correlated well with those from isothermal titration calorimetry 
(ITC, see below) under identical conditions.  It is important to note that results 
from the fluorescence anisotropy assay with (H3-H4)2 using the high salt buffer 
did correlate precisely with results from ITC experiments under identical buffer 
conditions (see below).  The measured KD value for the interaction between Spt6 
and gH2A-H2B in the EMSA assay was 1.5 µM (Figure 4-4B, open circles), 
which is only marginally tighter than the KD measured for full-length H2A-H2B 
using the same assay and conditions (2.5 µM, Figure 4-4B, closed circles).  We 
conclude that histone tails do not contribute to binding Spt6 and that this may be 
a necessary physiological requirement if Spt6 is needed to chaperone histones 
and reassemble nucleosomes that potentially have an assortment of chemical 
modifications.  One assumption behind this reasoning is that cells probably do 
not want to expend the energy to reestablish the chemical modification code for 
each gene after each passage of the transcription machinery.  Chaperones, 
therefore, likely reassemble each nucleosome with the same histones that were 
evicted prior to RNAPII passage, thereby maintaining the chemical code.    
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Spt6 does not bind the H3:H3 tertramerization interface 
 Structures of an unrelated histone chaperone called Asf1 were solved in 
complex with histones H3-H4 (Antczak et al., 2006; English et al., 2006; Natsume 
et al., 2007), revealing details of how other chaperones may interact with 
histones.  The most striking finding was that Asf1 bound H3-H4 at the H3:H3 
interface, thereby preventing tetramer formation and maintaining H3-H4 in a 
dimeric state.  The physiological significance of dimeric H3-H4 and the potential 
impact on proposed steps in the nucleosome (re)assembly pathway remain 
unclear; however, we wanted to assess whether Spt6 bound to H3-H4 in the 
same fashion as Asf1.  We made separate mutations in histone H3 (H114D and 
L127D) that prevent tetramer formation as assessed by size-exclusion 
chromatography (data not shown).  We used the fluorescence anisotropy assay 
to measure the KD values for the interaction between labeled Spt6-SBM and 
unlabeled dimeric H3-H4 (Figure 4-5A and B).  These results indicate that Spt6 
does not bind to the H3:H3 interface, as these mutations had no effect on binding 
affinity between Spt6 and H3-H4 as compared to WT (H3-H4)2 (WT KD = 1.3 µM 
vs. ~ 0.9 µM for the H3 mutants).  We conclude that although Asf1 may share a 
common function of chaperoning histones, Spt6 accomplishes its function by 
binding histones in a different manner.  Taken together, these results imply that 




!Figure 4-5.  Spt6 does not bind the H3-H3 tetramer interface.  
Binding isotherms derived from fluorescence anisotropy measurements 
of the interactions of two separate H3 mutants that prevent tetramer 
formation in solution (A, H3-H114D; B, H3-L127D) and fluorescently 
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Spt6 binds both histone subcomplexes with a 1:1 stoichiometry 
 We assessed the stoichiometry of the Spt6-(H3-H4)2 interaction and the 
Spt6-H2A-H2B interaction using ITC.  This quantitative binding assay determines 
the thermodynamic nature of an interaction, and reveals stoichiometries by 
measuring the heat released (or absorbed) in any amenable protein-protein 
binding reaction (Velazquez-Campoy et al., 2004).  Stoichiometry is measured by 
plotting the molar ratio of the protein being titrated into a cell containing the other 
binding partner.  This ratio, when plotted against the heat change of each titration 
point gives a sigmoidal relationship, which when fitted with a nonlinear regression 
curve allows for the measurement of not only the equilibrium binding constant 
and stoichiometry, but also the overall change in enthalpy of the reaction, 
allowing the calculation of entropic contributions to the binding reaction.  
Calorimetry is therefore the most powerful and comprehensive assay for 
measuring the thermodynamics of a binding reaction, and also benefits from the 
fact that no labels or tags need be included in the protein samples.   
 Using this assay, we measured the KD and stoichiometries of the reaction 
between Spt6(239-489) and (H3-H4)2 under high salt conditions (Figure 4-6A), 
and the reaction between Spt6-SBM and H2A-H2B under low salt conditions 
(Figure 4-6B).  The measured KD values in the ITC experiments correlate very 
well with those measured in the high salt fluorescence anisotropy assay with (H3-
H4)2 (1.3 µM with anisotropy and 2.0 µM with ITC), and the low salt EMSA assay 
with H2A-H2B (2.1 µM with EMSA and 1.26 µM with ITC).  The results of these 
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!Figure 4-6.  Spt6 binds with a 1:1 stoichiometry to histone tetramers 
and dimers.  
A) ITC measurements in high salt buffer (750 mM NaCl) of the interaction 
between Spt6(239-489) and (H3-H4)2.  Raw ITC data are shown in the 
top panel and the binding isotherm in the bottom panel. Thermodynamic 
parameters derived from ITC measurements, including stoichiometry (N), 
are given. 
B) As in (A), ITC measurements in low salt buffer (200 mM NaCl) of the 










































































reactions indicate that Spt6 binds to dimeric H2A-H2B in a 1:1 stoichiometry (one 
Spt6 molecule per H2A-H2B dimer).  Spt6 also binds to tetrameric (H3-H4)2 with 
a 1:1 stoichiometry (one Spt6 molecule per (H3-H4)2 tetramer).  The result of the 
stoichiometry between Spt6 and (H3-H4)2 is likely to be physiologically relevant 
even though the (H3-H4)2 tetramer is symmetric, and there likely exists two 
identical binding sites for Spt6 on a single tetramer.  Our preferred model is that 
the ordered core region of Spt6 prevents a second Spt6 molecule from interacting 
with the second binding site by steric occlusion.  
 The thermodynamic parameters of the Spt6-histone interactions in Figure 
4-6 are consistent with what we would expect given the buffer conditions and the 
measured affinities.  For the reactions with (H3-H4)2, the relatively high enthalpy 
values and the endothermic heat absorption profile imply a strong hydrophobic 
interaction.  This is expected given that we see binding in very high salt 
concentrations.  The large entropic value is likely a result of displacement of 
ordered salt and water molecules from the histone surface upon Spt6 binding.  
Another potential explanation of a large entropic value is that the Spt6 peptide 
might be largely ordered in the high salt buffer.  This would eliminate any 
decrease in entropy caused by the ordering of the peptide by binding to histones.   
 
Spt6 directly competes with DNA for histone binding 
 Recent work from the Luger laboratory indicated that at least two histone 
chaperones, FACT and Nap1, utilize a direct competition mechanism to 
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chaperone histones whereby they prevent nonspecific histone-DNA contacts 
(Andrews et al., 2010; Winkler et al., 2011).  This simple yet effective mechanism 
is an attractive model for all histone chaperones.  We tested Spt6 for its ability to 
compete with DNA for binding (H3-H4)2 using a heterologous equilibrium 
competition fluorescence anisotropy assay.  In these assays, concentrations of 
labeled (H3-H4)2 (0.5 nM) and full-length Spt6 were held constant, while a 207 bp 
DNA fragment was titrated.  The concentration of Spt6 was held at 6 nM, which 
corresponds to the KD of Spt6 for (H3-H4)2 under low salt conditions in the 
fluorescence anisotropy assay (Figure 4-7, closed circles).  The low salt 
conditions were used to reproduce the results from the Luger laboratory which 
indicated that a 207 bp DNA fragment, containing the Widom ʻ601ʼ nucleosome 
positioning sequence (NPS), binds (H3-H4)2 with a KD of 1 nM under low salt 
conditions (Andrews et al., 2008).  Our results with titration of a similar 207 bp 
DNA fragment (also containing the ʻ601ʼ NPS) into labeled (H3-H4)2 were 
essentially identical to the previously published results (KD of 2 nM).  
Interestingly, we found that Spt6 does indeed compete for histone binding with 
DNA; however, (H3-H4)2 prefers DNA binding under conditions where the 
concentration of DNA exceeds the KD of Spt6 for (H3-H4)2 (Figure 4-7, grey 
squares).  These data reveal that Spt6 is capable of binding (H3-H4)2 in the 
presence of low concentrations of DNA as indicated by the raw anisotropy signal 
being halfway between the signal of histones saturated with Spt6 and that of 
unbound histones (compare the unbound and saturated signal for the closed 
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!Figure 4-7.  Spt6 and DNA compete to bind (H3-H4)2. 
Binding isotherms derived from fluorescence anisotropy measurements 
of the interaction between Spt6 and (H3-H4)2 (closed circles) and the 
equilibrium competition reaction (grey squares) in low salt buffer (150 
mM KCl).  Competition reactions contain constant concentrations of Spt6 
and labeled (H3-H4)2 as indicated such that half of the histones are 
bound to Spt6 and a 1.6-fold dilution series of DNA was titrated into 








































































circles and the grey squares).  In these reactions, half of the histones are bound 
to Spt6.  Once the concentration of DNA in the titration exceeds the equilibrium 
binding constant of Spt6 for (H3-H4)2, the DNA effectively out competes Spt6 for 
histone binding and we see all of the histones become saturated with DNA.  
Therefore, Spt6 likely utilizes a direct competition mechanism similar to other 
histone chaperones to chaperone (H3-H4)2.  In a physiological context, this 
model also makes sense in that histones should be the preferred binding partner 
for genomic DNA and histones only need to be chaperoned when the DNA has 
somehow become disengaged; for example, when the effective local DNA 
concentration drops significantly, as it must during processes such as 
transcription. 
 
Functional implications for the histone chaperone activity of Spt6 
 The structural, genetic, and biochemical investigation of the Spn1-Spt6 
interface reported in Chapter 3 indicated that the interaction is important for 
maintaining a repressive chromatin state.  That study extended understanding of 
the histone chaperone activity of Spt6 by demonstrating that the region of the 
Spt6 protein required for binding Spn1 is also needed for interactions with 
nucleosomes and Spn1 antagonizes Spt6-nucleosome interactions in vitro.  The 
work in this chapter also strongly supports a role for Spn1 in Spt6-mediated 
nucleosome reassembly, perhaps by regulating the process or acting as a switch 
that drives disengagement.  Spt6 was also shown to compete with DNA for 
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binding to histones, indicating that Spt6 utilizes a direct-competition mechanism, 
similar to other histone chaperones (Andrews et al., 2010; Winkler et al., 2011), 




Protein expression and purification 
Spt6 proteins were cloned, expressed, and purified as previously 
described (Close et al., 2011; McDonald et al., 2010) with one modification; Spt6 
constructs with C-terminal truncations at or before residue 489 (including Spt6-
SBM) were purified via anion-exchange chromatography (5 mL Q HP, GE 
Healthcare) in place of a Heparin cation-exchange column after the Ni affinity 
purification.  Xenopus laevis histones were expressed recombinantly and purified 
from inclusion-bodies as described elsewhere (Luger et al., 1999).  ʻTaillessʼ 
histones were prepared by inserting a PreScission Protease site by PCR such 
that upon protease treatment (after refolding) a GP dipeptide remains N-
terminally fused to the following residues: H2A residues 14-118 (the C-terminal 
tail was removed by inserting two stop codons via site-directed mutagenesis 
reactions), H2B residues 24-122, H3 residues 27-135, and H4 residues 20-102.  
Purification of tailless histones was the same as for full-length histones, apart 
from protease treatment done in the presence of glutathione resin to remove the 
GST-labeled protease, and subsequent purification on a 120mL Superdex 200 
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16/60 (GE Healthcare) size exclusion column.  Fluorescent labeling of histone H4 
(T71C) and H2B (T112C) with Oregon Green-488 maleimide (Invitrogen) was 
performed according to manufacturers instructions prior to histone refolding and 
purification on a size exclusion column.  The Spt6-SBM protein was expressed 
recombinantly, purified as above, labeled with Oregon Green-488 maleimide 
(Invitrogen) on a Cysteine residue introduced by site-directed mutagenesis in the 
linker sequence that remains after TEV protease treatment, and purified from free 
dye on a size exclusion column.   
 
GST-Pulldown binding and competition assays 
N-terminal GST-Spn1(148-307) and GST-Spt6(239-1451) fusion proteins 
were cloned by LR reaction from a pENTR clone into the pDEST15 vector as per 
manufacturerʼs instructions (Invitrogen).  GST-tagged proteins were purified as 
described previously (McDonald et al., 2010) substituting a GST-sepharose 
column (GSTrap HP, GE Healthcare) for the Ni-NTA column.  Purified 
recombinant proteins were mixed at equimolar concentrations (2 µM) in a total 
volume of 300 µL and incubated for 1 hour at 4 °C.  Competition reactions 
contained 2 µM GST-Spn1(148-307) and Spt6(239-1451), and differing amounts 
of (H3-H4)2 (1.5-50 µM).  After the initial incubation, input samples were taken 
and 50 µL of washed glutathione sepharose beads (4 Fast Flow, GE Healthcare) 
were added to each reaction and incubated for another hour at 4 °C.  Beads were 
then washed three times (500 µL for each wash) with either low salt (200 mM 
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NaCl) or high salt (750 mM NaCl) binding buffer (15 mM Tris pH 7.5, 200 or 750 
mM NaCl, 5 % Glycerol, 2 mM 2-Mercaptoethanol, 0.5 mM EDTA, and 0.1 % 
Tween-20).  Proteins were eluted from beads by boiling in SDS-PAGE loading 
buffer for 10 min (Elution samples).  Samples were run on 15% SDS 
polyacrylamide gels using a Tris-Glycine running buffer and visualized with 
Coomasie staining.    
 
Fluorescence anisotropy 
All fluorescence polarization assays were incubated for 1 hr and measured 
at 25°C in 384-well flat bottom black (nonbinding surface) microplates (Corning).  
Purified Spt6 proteins were titrated in 1.6- to 1.8-fold serial dilutions against a 
constant concentration (0.5 nM) of refolded and labeled histones in either low salt 
buffer (20 mM Tris pH 7.5, 150 mM KCl, 2 mM MgCl2, 5 % glycerol, and 1 mM 
DTT) or high salt buffer (20 mM Tris pH 7.5, 750 mM NaCl, 5% glycerol, and 1 
mM DTT).  Anisotropy measurements and equilibrium dissociation constants (KD) 
were determined as described (Close et al., 2011) and plotted with GraphPad 
Prism software. Competition assays were performed by titration of 1.64-fold serial 
dilutions of a 207 bp DNA fragment against a constant concentration of both 
labeled histones (0.5 nM) and Spt6 corresponding to the measured KD for 




The 207 bp ʻ601ʼ nucleosome positioning sequence DNA fragment was 
amplified by PCR and purified by precipitation and gel extraction/electroelution.   
 
Native electrophoretic mobility shift assay 
 Purified recombinant proteins were incubated at room temperature for one 
hour in EMSA reaction buffer (15 mM Tris pH 7.5, 200 mM NaCl, 5% Glycerol, 
0.5 mM EDTA, 2 mM BME).  A 2-fold dilution series of H2A-H2B starting at 200 
uM concentration was made such that each reaction contained a constant 
concentration of Spt6-SBM (20 uM), and various concentrations of H2A-H2B.  
After incubation at room temperature, the reactions were subjected to 
electrophoresis on native 4-15% TGX gels (Bio-Rad) in 0.4x TBE at 110v for 40 
min at room temperature.  The gels were stained with Coomassie and band 
intensities were quantified using an Odyssey Imaging System (LiCor 
Biosciences). The fraction bound was calculated by quantifying the Spt6free (total 
band intensity of reaction containing no histones). Spt6 bound to histones does 
not enter a native gel and thus a reduction in Spt6free indicates binding to 
histones.  The fraction bound=1-([Spt6]free/∆[Spt6]free).  Equilibrium binding 
constants (KD) were calculated by plotting data points and curve fitting using 
GraphPad Prism software and the full quadratic expansion non-linear regression 
equation (LiCata and Wowor, 2008).    
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Isothermal titration calorimetry 
Purified recombinant proteins were dialyzed at 4°C overnight against 2 L 
of degassed high salt ITC buffer (20 mM HEPES pH 7.5, 750 mM NaCl, 0.5 mM 
EDTA, 5 % glycerol, and 2 mM 2-mercaptoethanol) for reactions with (H3-H4)2, 
or low salt ITC buffer (20 mM HEPES pH 7.5, 200 mM NaCl, 0.5 mM EDTA, 5 % 
glycerol, and 2 mM 2-mercaptoethanol) for reactions with H2A-H2B.  Titrations 
were done at 25°C on an iTC200 (Microcal) and spaced 180 s apart.  Spt6(239-
489) titrations were done with 1.8 µL injections of 1.25 mM Spt6 into 0.125 mM 
(H3H4)2.  H2A-H2B titrations were done with 1.8 µL injections of 0.075 mM H2A-
H2B into 0.6 mM Spt6-SBM.  Origin software (Microcal) was used for data 
analysis and determination of thermodynamic parameters as previously 
described (McDonald et al., 2010). 
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 Spt6 and Spn1 are transcription factors that bind one another and are 
each essential for yeast viability.  Although a broad role for both Spt6 and Spn1 
in transcription is clear, little is known of the precise mechanistic details for any of 
their proposed functions.  The structural and biochemical work reported in 
Chapter 2 established an atomic model of the five core domains and the C-
terminal domain of Spt6, and began to analyze potential binding partners.  The 
work in Chapter 3 extended our understanding of the structure of Spn1, 
structurally, biochemically, and genetically characterized the Spn1-Spt6 
interaction, and determined that the interaction is important biologically for 
maintaining a repressive chromatin state.  Chapter 4 further investigated the 
direct physical interaction between Spt6 and histones and established that Spn1 
indeed competes with histone for Spt6 binding, supporting a model in which the 
histone chaperone/ nucleosome reassembly activity of Spt6 is influenced by 
Spn1 binding.  This chapter will describe ongoing preliminary structural and 
biochemical studies on Spt6 and will discuss potential future approaches aimed 
at furthering our understanding of Spt6 and Spn1 function.  Our preliminary 
structural studies on the Spt6-H2A-H2B complex, which are being undertaken by 
Matt Sdano, have yielded protein-containing crystals that diffract to low (~7 Å) 
resolution.  Matt has also taken over crystallization trials on the Spt6-(H3-H4)2 
complex, which have thus far failed to yield protein crystals.  Matt Sdano has also 
developed a small-scale proteomics approach that will be exploited to identify 
and characterize new Spt6 and Spn1 binding partners from yeast lysates.  
Preliminary studies using this approach reveal interactions between the Spt6 C-
terminal domain and several factors involved in transcription, including Yra1, an 
mRNA export adaptor protein, and Tom1, an E3-ubiquitin ligase of the HECT-
class that is important for mRNA export and excess histone degradation.  Long-
term goals include structural, biochemical, and genetic characterization of 
confirmed direct binding partners.  Work in this chapter has been done in close 
collaboration with Matt Sdano and Devin Close, who have each contributed 
extensively to the search for new binding partners and the characterization of 
Spt6-histone interactions. 
 
Functional Implications For Spt6 and Spn1 
The Spt6 core and C-terminal domain structures 
 The crystal structures reported in Chapter 2 provide an atomic model for 
nearly all of the Spt6 protein that is predicted to be ordered.  The structures of the 
core of Spt6 revealed five domains with structural homology to other known and 
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well-characterized proteins.  It is likely that these domains contribute to the 
function of Spt6 by serving as recruiting modules during the transcription cycle of 
the many protein-coding genes that Spt6 influences.  Spt6 is required for 
recruiting factors that affect the maturation and export of the mRNA molecules 
produced during transcription (Andrulis et al., 2002; Bucheli and Buratowski, 
2005; Burckin et al., 2005; Kaplan et al., 2005; Yoh et al., 2007), and the Spt6 
core domains, which resemble nucleic acid-binding modules, appear poised to 
execute this function.  However, the contribution of each of the five core domains 
to the function of Spt6 remains enigmatic, and will be the focus of future 
research.  The C-terminal domain of Spt6 folds into a novel tandem SH2 domain, 
the only predicted SH2 domain in yeast (Maclennan and Shaw, 1993), and may 
bind directly to the phosphorylated tail of RNAPII (Diebold et al., 2010b; Sun et 
al., 2010; Yoh et al., 2007; Yoh et al., 2008).  It is possible, even likely, that each 
domain of Spt6 has multiple binding partners as the composition of the 
transcription elongation complex varies throughout the length of a gene.  Further, 
nearly every individual gene is regulated in a unique fashion (Martinez-Rucobo 
and Cramer, 2012; Treutlein et al., 2012; Yoh et al., 2007; Zhang et al., 2008) 
and Spt6 impacts a large number of genes (Mayer et al., 2010).  This means that 
interactions important for the proper transcription of one gene may not be 
required at other genes, creating a complicated, dynamic, and transient web of 
important interactions throughout the genome.  Teasing apart those interactions 
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that are physiologically relevant will be difficult and tedious, but clearly important 
to further our understanding of transcription and life. 
 
The Spn1 core structure 
 The structure of the ordered, central core of Spn1 revealed a novel eight-
helix-bundle fold.  The superhelical orientation of the fold is common among 
proteins with helical repeats, which come in multiple varieties including HEAT-
repeats, armadillo repeats, and TPR repeats (Andrade et al., 2001a; Andrade et 
al., 2001b).  Proteins with each of these repeat folds are found in the nucleus and 
include transcription factors such as ß-catenin (Huber et al., 1997), and the 
Swi2/Snf2 chromatin remodeler Mot1 (Wollmann et al., 2011).  The orientation of 
the last four helices of the Spn1 structure closely resemble the structure of the 
transcription factor TFIIS (PDB ID: 1wjt, RIKEN structural genomics/proteomics 
initiative), and therefore may be a common protein binding module utilized in 
various transcription complexes.  The structure also revealed the presence of a 
highly conserved, positively charged, deep pocket formed at the ends of helices 
1, 2, and 4 (Figure 3-2B and C).  The conservation suggests that this pocket is an 
important interaction surface and identifying other Spn1-interacting partners will 
be another focus of future research. 
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The structure of the Spn1-Spt6 complex 
 The structure of the complex between Spt6 and Spn1 provided atomic 
details of how the disordered N-terminal segment of Spt6 becomes ordered upon 
binding to the Spn1 core, and the extensive interface seen in the structure is 
consistent with the strong specific binding observed in solution.  One striking 
feature of the interface is the deep hydrophobic pocket formed by the last three 
helices at the C-terminus of Spn1, which contacts the highly conserved 
hydrophobic Spt6 residues I248 and F249.  This strong hydrophobic portion of 
the interface appears to be conserved in sequence and utilized by other 
transcription factors, with helical arrangements and hydrophobic pockets similar 
to that of Spn1 found in TFIIS, Elongin A, and Med26 (Diebold et al., 2010a), and 
the IF motif of Spt6 that binds the hydrophobic pocket of Spn1 is found and 
conserved in multiple subunits of the SAGA and Mediator complexes (Diebold et 
al., 2010a).   
The extended and inherently flexible nature of the Spn1 binding sequence 
of Spt6 presumably explains why dramatic mutations in the interface substantially 
weaken but do not completely eliminate this interaction, as localized 
perturbations can be accommodated by conformational changes that do not 
propagate across the entire interface. Moreover, the approximately 35 residues 
separating the Spn1-binding residues from the ordered core of Spt6 likely provide 
a tether whose flexibility may be required to allow the Spn1-Spt6 complex to form 
in multiple functional contexts.  The use of the inherently flexible N-terminal 
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segment of Spt6 that binds the Spn1 core may provide a mechanism that allows 
flexibility in a crowded transcriptional environment. 
 
Histone chaperone activity of Spt6 
 The structural, genetic, and biochemical investigation of the Spn1-Spt6 
interface reported in Chapter 3 indicated that the interaction is important for 
maintaining a repressive chromatin state.  Our studies have extended 
understanding of the histone chaperone activity of Spt6 by demonstrating that the 
region of the protein required for binding Spn1 is also needed for interactions with 
nucleosomes and free histones.  Our data presented in Chapter 4 also strongly 
supports a role for Spn1 in Spt6-mediated nucleosome reassembly, perhaps by 
regulating the process or acting as a switch that drives disengagement.  Spt6 
was also shown to compete with DNA for binding to histones, indicating that Spt6 
utilizes a direct-competition mechanism, similar to other histone chaperones 
(Andrews et al., 2010; Winkler et al., 2011), to accomplish the chaperoning of 
histones required for the proper reassembly of nucleosomes.  
 
Biochemical Analysis of Spt6 
Preliminary crystallization of Spt6 in complex with histones H2A-H2B 
 In studies complimentary to our analysis of Spt6-histone interactions, Matt 
Sdano has begun crystallization trials with the Spt6-SBM and the two different 
histone subcomplexes.  Preliminary trials with (H3-H4)2 have failed to produce 
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protein crystals, although many options remain to be tested, including using 
ʻtaillessʼ histones, combinations of full-length and ʻtaillessʼ histones, and varying 
the amount of the Spt6 peptide.  Preliminary trials with H2A-H2B have yielded 
protein-containing crystals grown from drops that contained equimolar 
concentrations of the Spt6-SBM and full-length H2A-H2B (Figure 5-1A).  These 
crystals diffract poorly to a resolution of about 7 Å (Figure 5-1B), and efforts to 
determine the crystalline lattice space group have been unsuccessful.  Mass 
spectrometry analysis of the crystals suggest that the histone proteins are 
present in the crystals, but the presence of the Spt6-SBM could not be 
determined due to the presence of similar molecular weight polyethylene glycol 
polymers in the crystallization buffer.  Efforts to improve crystal packing and 
diffraction are ongoing.  Structural data may also be obtained by using NMR, and 
the studies by Yawen Bai and colleagues (Zhou et al., 2008; Zhou et al., 2011) 
provide precedent that histones are amenable to NMR experiments, including the 
necessary isotope labeling by expression in minimal media. 
 
Identifying new Spt6 and Spn1 binding partners 
 A small-scale proteomics approach has been developed by Matt Sdano to 
screen for new Spt6 and Spn1 binding partners in yeast.  This approach takes 
advantage of the inducible GAL1 promoter to drive the overexpression of proteins 
with an N-terminal tandem strep and flag-epitope tag.  This allows for easy 
tandem affinity purifications where the eluates are separated by SDS-PAGE and 
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!Figure 5-1.  Preliminary structural work and identification of new 
Spt6 binding partners 
A) Putative crystals of an Spt6-H2A-H2B complex.  Crystals were grown at 
20 °C in drops comprised of  0.3 µL of 5.7 mg.mL-1protein (a 1.1: 1 molar 
ratio of Spt6-SBM:H2A-H2B) and 0.3 µL of well solution (0.2 M [NH4]2SO4, 
0.1 M Bis-tris [pH 5.5], 25% PEG 3350). 
B) X-ray diffraction image collected from a crystal in (A). 
C) SDS-PAGE of the TAP purification of the Spt6 tSH2 domain (residues 
1247-1451) expressed in yeast.  The bands of putative interacting 
partners are indicated and identified by mass spectrometry.  TAP-
purification lanes were either untreated (-) or treated (+) with calf-intestinal 
phosphatase (CIP) to identify partners that bind in a phosphorylation 
dependent manner.  The previously identified Spt6-interacting subunits of 
RNA polymerase II (Rpb1 and Rpb2) are indicated. Bands were visualized 


















interacting protein bands are identified using mass spectrometry.  Matt has used 
this approach to identify binding partners of the Spt6 C-terminal tSH2 domain 
(Figure 5-1C), including Tom1, a HECT domain containing E3 ubiquitin-ligase 
important for mRNA export and excess histone degradation (Saleh et al., 1998), 
and the mRNA export adapter Yra1 (Strasser and Hurt, 2000).  Further 
confirmation of direct interactions will employ techniques such as surface 
plasmon resonance and ITC.   
 In order to assess the amenability of proteins or individual protein domains 
for use in this system, we test for expression and solubility in bacteria, and 
employ standard purification techniques including size exclusion chromatography 
to ensure monodispersity in solution.  This is necessary to avoid overexpressing 
proteins or domains that tend to aggregate, or form soluble aggregates that 
would yield unreliable or misleading results.  If necessary, CD spectroscopy can 
also be used to assess whether the expressed protein appears to have folded 
properly.  Alternative approaches to this system will employ genomic tagging of 
proteins to allow for purification and identification of binding partners of proteins 
expressed from their native promoters at endogenous levels.  To this end we 
have successfully cloned, expressed and purified Spn1, the Spn1 core, and the 
Spt6 HtH domain from bacteria.  We are currently cloning and testing the other 
individual domains of Spt6.  The overall goal will be to try to identify 
physiologically relevant binding partners for Spn1 and each Spt6 domain.  Once 
viable candidates have been identified, we will thoroughly characterize the 
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importance of these interactions using the structural, biochemical, and genetic 




 The multiple functional roles of Spt6 and Spn1 and their requirement for 
yeast viability make each exciting targets for precise mechanistic analyses.  The 
work in this dissertation has expanded upon the foundational structural and 
biochemical work on Spt6 of Sean Johnson and Devin Close, both former 
members of the Hill lab.  The primary focus has been the flexible, disordered, and 
highly negatively charged N-terminal region of Spt6, which contributes to 
interactions with both Spn1 and histones.  We have provided evidence of a novel 
functional role for Spn1 in the regulation of the histone chaperone and 
nucleosome reassembly activity of Spt6.  Further, we have determined that Spt6 
chaperones histones by direct-competition with DNA, which provides mechanistic 
details about the Spt6-histone interface and indicates how Spt6 accomplishes 
nucleosome reassembly.  The precise mechanistic details of how Spn1 
influences nucleosome reassembly in vivo remain an important obstacle and 
focus of future work.  Ongoing work includes structural, biochemical, and genetic 
studies to more accurately dissect and define mechanisms that contribute to the 
multiple functions of both Spn1 and Spt6.  This includes a more accurate 
description of the interfaces formed upon Spt6 binding to the two different histone 
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